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i 
RIASSUNTO 
La maggior parte delle malattie emergenti è di origine zoonotica. La globalizzazione e 
l’allevamento intensivo hanno contribuito ad un aumento della diffusione delle infezioni 
zoonotiche ed è quindi di fondamentale importanza poter conoscere ed essere preparati a 
gestire eventuali epidemie. L’infezione da virus influenzali di tipo A è una zoonosi che mette 
a rischio la sanità pubblica. Alcuni sottotipi di virus influenzali hanno superato con successo 
la barriera di specie e si sono adattati ai mammiferi e alla popolazione umana, causando 
epidemie annuali e stagionali. Il virus influenzale del sottotipo H9N2 è classificato come virus 
influenzale a bassa patogenicità e infetta soprattutto le specie aviarie. Dalla metà degli anni 
’90, questo sottotipo ha causato infezioni nei volatili selvatici e nell’industria avicola in 
diversi paesi dell’Asia, Europa, Nord Africa e America. L'ampia diffusione di virus H9N2 in 
tutta l'Eurasia, insieme con la loro capacità di causare infezione diretta nei mammiferi e 
nell'uomo, ha destato preoccupazione in merito a un suo potenziale impatto sulla salute 
pubblica come possibile candidato per la prossima pandemia influenzale. 
Questa tesi di dottorato si occupa dello studio filogenetico e filogeografico, della 
classificazione genetica e dell’evoluzione molecolare dei virus influenzali del sottotipo H9 
presenti in tutto il mondo. Particolare interesse è stato rivolto allo studio dell'emoagglutinina 
virale e attraverso analisi bioinformatiche è stata analizzata una grande quantità di dati e di 
sequenze dei virus H9 isolati nel mondo e creato un sistema di nomenclatura uniforme che 
fornisce al mondo scientifico una chiave di lettura e chiarisce la relazione genetica tra i diversi 
ceppi del sottotipo H9 dal momento della loro comparsa a oggi. L’approccio filogeografico ha 
inoltre contribuito a chiarire le dinamiche evolutive e la diffusione spazio-temporale tra 
gruppi genetici e diversi virus H9N2 dell'influenza aviaria. 
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Sono state elaborate in modo più dettagliato le dinamiche evolutive del virus H9N2 in un 
paese endemico come l'Iran. Studi filogenetici e molecolari sono stati eseguiti su tutti i virus 
iraniani H9N2 circolati dal 1998 al 2015, insieme alle sequenze dei virus circolanti nei paesi 
confinanti. I risultati hanno portato a identificare le relazioni filogenetiche delle varie 
introduzioni e la diffusione ad altri paesi, a evidenziare le dinamiche evolutive e la portata del 
suo cambiamento molecolare dal primo rilevamento in Iran e dopo l'applicazione di un 
programma di vaccinazione. 
Inoltre, tra gli obiettivi del progetto di ricerca c’era quello di investigare la sieroprevalenza 
per il virus H9N2 tra i lavoratori del settore avicolo per capire se in un paese endemico come 
l’Iran dove, malgrado rigorosi piani di sorveglianza e vaccinazione, il sottotipo H9N2 circola 
da diversi anni nell’industria avicola creando molti danni economici. Questo studio è stato 
eseguito in collaborazione con un gruppo di ricerca iraniano per scoprire l’associazione tra 
l’esposizione agli avicoli e la presenza degli anticorpi verso il virus influenzale H9N2 allo 
scopo di rafforzare le misure di sorveglianza e controllo e monitorare il rischio biologico e 
quindi di preservare la salute pubblica dalla diffusione di tali virus influenzali. 
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SUMMARY 
Most emerging diseases are of zoonotic origin. Globalization and intensive animal farming 
has led to an increased spread of zoonotic infections and it is therefore of crucial importance 
to be prepared in managing potential outbreaks. Influenza type A virus is cause of a zoonotic 
disease, which can affect animal and human health. A number of influenza virus subtypes 
have successfully crossed the species barrier and have established in mammal and human 
populations, causing yearly seasonal epidemics. The influenza A viruses of the H9N2 subtype 
are classified as low pathogenic avian influenza (AI) viruses which infect mostly avian 
species. The H9N2 type has caused infections both in wild birds and in the poultry population 
around the globe, including several countries in Asia, Europe, North Africa and Americas 
since the mid-1990s. The wide circulation of H9N2 viruses throughout Eurasia, along with 
their ability to cause direct infection in mammals and humans, raises public health concern 
about their potential to become candidates for the next influenza pandemic. 
This Ph.D. thesis deals with phylogenetic and Bayesian phylogeographic analyses, genetic 
nomenclature and molecular evolutionary dynamics to elucidate the different aspects of H9 
subtypes circulating worldwide. Focusing on the hemagglutinin gene through the application 
of bioinformatics tools a large amount of H9 subtype strains global data have been analysed 
and a unified nomenclature system have been designed producing a lot of data that 
contributed to clarify the evolution dynamics of H9 subtype viruses identified to date. 
The evolutionary dynamics of H9N2 in an endemic country as Iran have been elaborated 
in further detail. Phylogenetic and molecular studies have been performed on all the H9N2 
Iranian viruses circulating from 1998 to 2015 along with other neighboring countries to 
identify the phylogenetic relationships grouping the various introductions and the spread to 
other countries, in order to highlight the evolution dynamics and the extent of its molecular 
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change since the H9N2 first detection in Iran and after the application of a vaccination 
program. 
In addition, one of the research topics includes a serological investigation of H9N2 avian 
influenza virus among the poultry workers in an endemic country as Iran where, despite of the 
control measures implemented at national level including mass vaccination of poultry, the 
subtype H9N2 has rapidly spread and can be considered endemic in Iranian poultry. This 
study has been carried in collaboration with an Iranian research group to reveal the 
association between professional exposure to poultry and the presence of antibodies to H9N2 
viruses in order to develop surveillance and control programs to monitor the biological risk 
and thus to preserve public health against the spreading of the H9N2 virus. 
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Chapter 1 
 
BACKGROUND 
 
Influenza virus 
Classification 
Influenza viruses belong to the Orthomyxoviridae family; antigenic differences in their 
nucleoprotein (NP) and matrix protein (M1) allow influenza viruses to be classified in five 
different genera: Influenzavirus A, Influenzavirus B, Influenzavirus C, Isavirus, and 
Thogotovirus (Webster et al., 1992; Ducatez et al., 2015). Influenza A virus is further 
subtyped based on the antigenic properties of the surface glycoprotein hemagglutinin (HA) 
and neuraminidase (NA). The HA and NA subtypes have been found in a great variety of 
combinations in nature. To date, eighteen HA (H1–H18) and eleven NA (N1–N11) subtypes 
have been identified. Aquatic birds are considered the major influenza A viruses reservoir in 
nature harbouring diverse combinations of the HA and NA subtypes. H17N10 and H18N11 
viruses have only recently been described in bats (Tong et al., 2013). 
A standard naming system for the identification of these viruses is used, starting with the 
specific genus and followed by species of isolation, geographical location, isolate number, 
and year of isolation. The antigenic description of the HA and NA subtypes follows in 
parentheses. The naming system for most human influenza viruses follows the same format, 
but the species of isolation is not included, though early influenza isolates such as A/Wilson-
Smith/33 (H1N1) include the names of the scientists involved rather than the place of 
isolation (Cox et al., 2010). 
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Etiology 
Genome and proteins 
Influenza A viruses are enveloped single stranded negative sense RNA viruses. They are 
pleomorphic, mostly found as spherical or ovoid shaped particles, measuring 100-300 nm in 
diameter following in vitro passage, while filamentous particles up to 30 μm are typical of 
primary or low-passage isolates (Seladi-Schulman et al., 2013). 
Their genome consists of 8 segments (from 0.9 to 2.3 Kb), which encodes for at least 
seventeen genes (Table 1), fifteen of which are structural and non-structural proteins (Figure 
1). 
Gene 
Segment 
Relative Size 
(nucleotides) 
Gene Products 
Polypeptide Length 
(amino acids) 
Categories  
1 - PB2 2341 PB2 759 Internal 
2 - PB1 2341 
PB1 757 Internal 
PB1-N40 718 Internal 
PB1-F2 90 (or truncated) Internal 
3 - PA 2233 
PA 716 Internal 
PA-X 252 Internal 
PA-N155 568 Internal 
PA-N182 535 Internal 
4 - HA 1778 HA 566 Surface 
5 - NP 1565 NP 498 Internal 
6 - NA 1413 NA 454 Surface 
7- M 1027 
M1 252 Internal 
M2 97 Surface 
M42 99 Surface 
8 - NS 890 
NS1 230 non-structural 
NS2 (NEP) 121 non-structural 
NS3 174 non-structural 
 
Table 1. Influenza A virus gene segments, their relative sizes, and encoded proteins. 
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Figure. 1. Graphical representation of the spherical shape of influenza A virus and its 
genome. The ssRNA(-) genome is encapsidated by nucleoprotein and consists of 8 segments 
with a size range between 890 and 2341 nt and encodes for 12-14 proteins (depending on the 
strain). From ViralZone, SIB Swiss Institute of Bioinformatic (http://viralzone.expasy.org/). 
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Segment 1: PB2 polymerase. The basic polymerase protein 2 (PB2) is a cap-binding 
protein essential for the synthesis of mRNA (Plotch et al., 1979); at the beginning of the 
transcript it recognizes and binds the cap to the 5 'RNA end of the host, and it is partially 
involved in cap snatching so that it can be used as a primer for the viral RNA synthesis. 
(Webster et al., 1992). Associated with host range restriction. 
Segment 2: PB1 polymerase, PB1-F2 and N40. The basic polymerase protein 1 (PB1) is 
the main polymerase protein responsible for the elongation of the primed nascent viral mRNA 
and template RNA and for the vRNA synthesis (Webster et al., 1992). Segment 2 also 
encodes for the PB1-F2 protein in an alternate reading frame, which appears to be involved in 
cell apoptosis (Zamarin et al 2006). A third major polypeptide is synthesized from PB1 
mRNA via differential AUG codon usage. PB1 codon 40 directs translation of an N-
terminally truncated version of the polypeptide (N40) that lacks transcriptase function; 
nevertheless, interacts with PB2 and the polymerase complex in the cellular environment 
(Wise et al., 2009). 
Segment 3: PA polymerase and PA-X. The acid polymerase protein (PA) (a) has 
endonuclease and protease activities, (b) is involved in viral RNA or complementary RNA 
promoter binding and (c) interacts with the PB1 subunit (Das et al., 2010). It has recently 
been demonstrated that segment 3 of the virus contains a second open reading frame (X-
ORF), accessed via ribosomal frameshifting. The frameshift product, termed PA-X, comprises 
the endonuclease domain of the viral PA protein with a C-terminal domain encoded by the X-
ORF and functions to repress cellular gene expression. Loss of PA-X expression leads to 
changes in the kinetics of the global host response, which increases inflammatory, apoptotic, 
and T lymphocyte-signaling pathways (Jagger et al., 2012). In addition, novel PA-related 
proteins in influenza A virus-infected cells have been recently identified. These new proteins 
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are translated from the 11
th
 and 13
th
 in-frame AUG codons in the PA mRNA and are, 
therefore, N-terminally truncated forms of PA, named PA-N155 and PA-N182, respectively. 
The function of these proteins needs to be investigated (Muramoto et al., 2013). 
Segment 4: Hemagglutinin. The hemagglutinin (HA) is the most abundant antigenic 
glycoprotein of the viral surface encoded by the 4
th
 viral segment of the influenza A genome. 
It is a type I membrane glycoprotein responsible for the binding of the virus to the receptors 
present in the host cell surface, for virus internalization and fusion with the endosomal host 
membrane. In the viral particles, each mature HA is a homotrimer which projects onto the 
viral envelope to form a rod-shaped structure; in infected cells, this protein is synthesized as a 
precursor polypeptide, called HA0, which must be cleaved into two subunits (HA1 and HA2, 
of 36 and 27 kDa, respectively) by host trypsin-like proteases (Copeland et al., 1986). After 
the proteolitic cleavage of the precursor, the two subunits are covalently linked to each other 
by a disulfide bond, whereas each trimer is associated to the others by non covalent bonds 
(Klenk et al., 1975). This processing is necessary for the virus infectivity because it activates 
the fusion of HA and it is a determinant of pathogenicity (Hamilton et al., 2012). The 
cleavage site is a prominent surface loop near a cavity in HA0 (Chen et al., 1998); the results 
of the cleavage process is a structural rearrangement in which the fusion peptide, formed by 
nonpolar N-terminus amino acids of HA2, is relocated into the interior of the trimer and 
buries ionizable residues involved in the acidification-induced conformational changes in the 
endosome. At the membrane-distal tip of each HA1 the receptor binding domain (RBD) is 
present, which is formed by the 130-loop, 190-helix, and 220-loop and four highly conserved 
sites (Weis et al., 1988, Martín et al., 1998); it forms the sialic acid binding pocket and 
contains most of the antigenic regions recognized by neutralizing antibodies (Abs). The stem-
like structure HA2 has a membrane fusion activity. The 2 loops and the helix contain amino 
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acids that interact either with sialic acids or with internal sugars of the glycan chain associated 
with glycoproteins and glycolipids on the surface of epithelial cells; the base of the site 
contains several highly conserved residues that form an extensive hydrogen bond network. 
The three-dimensional structure of few HA subtypes has been resolved and characterized with 
respect to the localization and structure of their antigenic sites. In the H3 subtype, five 
antigenic sites (A, B, C, D, E) have been mapped (Wiley et al., 1992), and the same structure 
was used to map antigenic sites on the H1 and H2. When the 3D structures of H5 and H9 HA 
were resolved, the H5 HA molecule was antigenically mapped. For H5 structure, the 
localization of two antigenic sites has been described. Site 1 includes residues 140 to 145 in 
HA1 (H3 numbering). Changes in the HA and NA antigenic combinations of a virus 
(antigenic shift) may derive from the genome segmentation. When the same cell is co-infected 
by distinct viral subtypes, the viral progeny may originate from a reassortment of parental 
genes from different viruses. 
Segment 5: Nucleoprotein. The nucleoprotein (NP) is the core of the ribonucleoprotein 
(RNP) complex binding the vRNA with the polymerase complex. It has also been suggested 
that NP controls the switching of the RNA polymerase from transcription to replication 
(Shapiro and Krug, 1988). 
Segment 6: Neuraminidase. Segment 6 encodes for another integral membrane 
glycoprotein, the neuraminidase (NA), which is homotetramer of 220 kDa consisting of a 
head, which is an enzymatically active domain, and a tail which allows to anchor the protein 
to the membrane (Hausmann et al., 1997). Its main functions are i) hydrolysis of sialic acid on 
the cellular receptor for the hemagglutinin, which allows the release of the virus from the cell 
surface, and ii) removal of sialic acid residues from the viral particles to prevent aggregation. 
The inhibitors developed for this enzymatic protein are the main antiviral drugs. In the 
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absence of this enzyme the virus remains attached to the cellular receptors, thus inhibiting the 
spread of the virus progenies in the host tissues. Therefore, antibodies directed against the 
neuraminidase protein do not prevent infection but reduce the spread of the virus in tissues. 
Segment 7: M1 and M2. Segment 7 contains two overlapping reading frames encoding for 
two proteins, matrix protein 1 (M1) and matrix protein 2 (M2), which are translated from 
spliced mRNAs (Lamb et al., 1981). The M1 protein forms a layer to separate the RNPs from 
the viral envelope and is involved in numerous functions related to the assembly and 
disassembly of viral particles, the transport of the RNPs to the nucleus, the nuclear export of 
viral proteins and viral morphology (Martin and Helenius, 1991). M2 is a tetramer integral 
membrane protein situated within the viral membrane as a proton ion channel that regulates 
the pH level. Its activity is essential for viral infection of host cells (Pinto et al., 1992). 
Segment 8: NS1 and NS2. The smallest viral segment 8 contains two overlapping reading 
frames, which require mRNA splicing, that encode for two proteins: nonstructural protein 1 
and 2 (NS1 and NS2). NS1 is the main non structural protein, involved in host cell processes 
to promote viral protein synthesis, as well as in sequestering cellular mRNAs in the nucleus 
so that their caps may be used as primers for viral mRNA synthesis (Qian et al., 1994). NS1 
also sequesters dsRNA to prevent induction of the host interferon response (Kochs et al., 
2007). NS2 is frequently referred to as the “nuclear export protein” NEP) for its role in 
transporting newly synthesized RNP from the nucleus to the cytoplasm (O'Neill et al., 1998). 
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Infection and replication cycle 
The influenza A virus takes advantage of the host cell machinery in almost all the phases 
of its replication. This process begins with receptor recognition and binding by the viral 
hemagglutinin (HA). Attachment is mediated by an interaction between the receptor binding 
site of the HA molecule and sialic acid (SA)-containing glycoconjugates on target cells. The 
nature of the SA linkage to its underlying galactose is considered the first major determinant 
for successful infection, as avian-tropic viruses preferentially recognize and bind to SAs with 
an alpha-2,3 linkage to galactose, while human-tropic viruses generally bind SAs with alpha-
2,6 linkages. After binding to the host cell, the virus is internalized through the endosomal 
pathway; the acidification of the vesicle causes a conformational change of the hemagglutinin, 
which exposes the N-terminal hydrophobic domain of the HA2 chain (site of fusion) and 
causes its interaction with the endosomal membrane. The viral envelope and the endosomal 
membrane are then merged and the viral nucleocapsid is released into the cytoplasm of the 
host cell (Figure 2). This fusion occurs thanks to the cleavage of the HA0 precursor molecule 
into the HA1 and HA2 subunits by the host cell proteases (Skehel et al., 1982; Bullogh et al., 
1994). 
Following viral entry, H ions flood through the M2 ion channel, causing the separation of 
the M1 from the RNPs to allow the transport of the RNPs from the cytoplasm into the 
nucleus, mediated by the nuclear localization signal (NLS) located at the extreme N-terminus 
of nucleoprotein (NP). 
All the vRNA synthesis processes, including viral transcription, replication and assembly 
of vRNPs occur in nucleus. In the host cell nucleus, the viral RNA polymerase complex (PB1, 
PB2, PA) uses the negative sense vRNA as template to synthesize two different types of 
single-stranded positive RNA segments: cRNA (complementary RNA) used by RNA 
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polymerase to produce many copies of vRNA (viral RNA) and mRNA (messenger RNA) 
(Herz et al., 1981). 
In influenza virus infected cells, the nuclear export of cellular mRNAs is blocked; the 
cellular pre-mRNA and mRNA are degraded in the nucleus. This nuclear export block is 
selective: all viral mRNAs are efficiently exported; as a consequence, these newly synthesized 
mRNAs prevail in reaching the translation machine into the cytoplasm of infected cells, thus 
helping to permanently stop the gene expression of the host cell and selectively synthesize 
viral proteins. The nuclear export of the viral mRNA uses the host cell machinery but it is 
selective: it is controlled by a viral non-structural protein (NS1) that inhibits the expression of 
mRNA synthesized after the cell infection. Furthermore, the pre-mRNA and mRNA retained 
in the cell nucleus are available to the cap dependent viral endonuclease for the production of 
the capped RNA primers required for viral mRNA synthesis. 
Viral mRNAs, after being transported into the cytoplasm, are translated to produce the 
corresponding proteins by the host ribosome. The membrane proteins (HA, NA and M2) are 
transported by the RER and the Golgi apparatus to the plasma membrane. When nucleocapsid 
and viral coat proteins reach the plasma membrane, they form a bud which coating contains 
proteins immersed in the lipids bilayer of the host cell. Subsequently the bud separates and 
virus particles are released outside the cell. During viral budding the host proteins present in 
the plasma membrane are excluded from the final viral particle. The viral proteins possessing 
a nuclear localization signal are transported into the nucleus (PB1, PB2, PA, NP, M1, NS1 
and NS2). The progeny virions from infected cell be released from the cell upon NA cleavage 
of host sialic acid receptors (Baigent and McCauley, 2003; Figure 2). 
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Figure 2. Influenza A virus replication. 1) A virion attaches to the host cell membrane using 
HA and enters the cytoplasm by receptor-mediated endocytosis, thereby forming an 
endosome; 2) HA2 promotes fusion of the virus envelope and the endosome membranes. M2 
acts as an ion channel making the inside of the virion more acidic. As a result, the major 
envelope protein M1 dissociates from the nucleocapsid and vRNAs are translocated into the 
nucleus; 3) In the nucleus, the viral polymerase complexes transcribe (3a) and replicate (3b) 
the vRNAs; 4) Newly synthesized mRNAs migrate to cytoplasm where they are translated; 5) 
Post-translational processing of HA, NA, and M2 includes transportation via Golgi apparatus 
to the cell membrane (5b); NP, PB2, PB1 and PA move to the nucleus (5a) and bind the newly 
synthesized copies of vRNAs; 6) The nucleocapsids migrate into the cytoplasm and 
eventually interact via protein M1 with a region of the cell membrane where HA, NA and M2 
have been inserted; 7) NA destroys the sialic acid moiety of cellular receptors, releasing the 
progeny virions from infected cell.   
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Evolution 
Antigenic drift and shift 
As for all RNA viruses, Influenza A viruses are dynamic and evolve continuously. Their 
evolution is mostly characterized by the combination of high mutation rate, rapid replication 
and infection of large populations. High mutation rate and reassortment of the segmented 
genome are the mechanisms that allow influenza viruses to rapidly evolve and avoid 
neutralization by pre-existing antibodies in the exposed population. Antigenic variation of the 
HA and NA surface glycoproteins occurs through two diverse mechanisms. The first is known 
as antigenic drift. The antigenic drift refers to the small gradual accumulation of amino acid 
changes that occur through point mutations; these may happen unpredictably and result in 
minor changes of the influenza genome. When they occur in the two genes codifying for the 
main surface glycoproteins (HA and NA), new virus strains that may not be recognized by 
antibodies to earlier influenza strains may be produced. Antigenic drift is caused by 
spontaneous mutations resulting from a lack of proof-reading by the virus polymerase, and 
variations are thought to occur at a rate of less than 1% each year. However, after a few years 
of continued accumulation a new variant strain will become predominant and cause the next 
rounds of seasonal epidemics (Cox et al., 2010). Antigenic shift refers to an abrupt, major 
change to produce a novel influenza A virus subtype. Due to their segmented nature, 
influenza genomes can be readily mixed in host cells infected with more than one virus. As a 
consequence, new strains can suddenly be produced by reassortment. For example, when a 
cell is infected with influenza viruses from different species, reassortment can result in 
progeny viruses containing genes from strains that normally infect birds, and genes from 
strains which normally infect humans. This leads to the creation of new strains which may 
cause influenza pandemics in humans, as observed in the case of the 1957 and 1968 
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pandemics (Clancy et al., 2008). While influenza viruses change by genetic drift commonly, 
genetic shift happens only occasionally. 
 
Avian influenza and pathotypes 
Avian influenza viruses can be classified into two groups based on the severity of clinical 
disease: low pathogenic (LPAI) or highly pathogenic (HPAI) form. LPAI virus infections in 
poultry can be asymptomatic or cause mucosal infection, with mild to severe respiratory 
disease, water and feed decrease and drops in egg production; usually they do not result in 
high mortality of the infected hosts. To date, only H5 and H7 subtypes of influenza A viruses 
have shown to be able to evolve from a LPAI to a HPAI. When LPAI viruses of the H5 or H7 
subtype are transmitted from wild birds to poultry, they may mutate into HPAI viruses. In 
poultry, HPAI viruses usually cause systemic infections and are associated with severe 
disease and high mortality reaching 100% within 48 hours of infection. 
From a molecular point of view, this pathogenicity lies in the sequence at the HA0 
cleavage site, which depends on host proteases for cleavage into its HA1 and HA2 subunits 
for functionality. LPAI viruses contain a single arginine at the cleavage site, limiting cleavage 
to a small number of extracellular host proteases and thereby restricting tissue tropism to 
anatomical sites where such proteases are found. Conversely, highly pathogenic viruses 
contain multiple basic amino acids at the HA0 cleavage site, permitting cleavage by 
ubiquitous intracellular proteases and ultimately allowing for systemic spread of the virus 
(Capua & Alexander, 2008; Taubenberger, 1998). HPAI isolates generally emerge after their 
low pathogenic precursors are introduced from wild birds into domestic poultry flocks. In 
these new host populations, viruses acquire the highly pathogenic cleavage site by either 
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stuttering of the polymerase during replication or rarely via non- homologous recombination 
with other viral gene segments (Webster, 2006). 
In addition to the H5 and H7 subtypes, also some H10 viruses fall within the definition of 
HPAI (Alexander, 2008). The H10 subtypes have characteristics of the HPAI pathotype. 
However, these viruses do not possess a multi-basic cleavage site and do not cause systemic 
infection. When these viruses are administered intravenously into poultry, they cause the 
death of the host by impairing the function of the kidney (Swayne and Alexander, 1994). A 
recent study reported a nephritic H10N1 avian influenza virus that did not display multiple 
basic amino acids at the cleavage site although it showed an intravenous pathogenicity index 
(IVIP) of 1.9. Furthermore, when administered by a natural route (intranasal), this H10N1 
virus may cause mortality (Bonfante et al., 2014). To date, the World Health Organization 
(WHO) considers H5, H7 and H9 avian influenza subtypes as those with the greatest 
pandemic potential. The spread of HPAI and LPAI viruses of the H5, H7 or H9 subtypes 
amongst birds and sporadic infections in humans continue to pose a threat to public health 
(Lin et al., 2000). 
 
Host Specificity and Interspecies Transmission 
To successfully cross the species barrier, the virus must overcome several constraints 
either at virus and host level. Binding preference of viruses to host cells is considered to be 
one of the most relevant determinant that prevents crossing the species barrier and influence 
viral tropism. Sialic acids (SAs) are present on the surface of many cell types and animal 
species; in general, carbon-2 of the terminal sialic acid is bound to the carbon-3 or carbon-6 of 
an adjacent galactose, which allows the formation of an α2,3- or α2,6-linkage configuration. 
The hemagglutinin of avian and equine influenza viruses usually has a binding preference for 
  
 
16 
α2,3-linked sialic acid; human isolates exhibit α2,6-linkage, whereas viruses from swine bind 
to both. More recently it has been demonstrated that the human epithelial cells of the lower 
respiratory tract harbour SAs with both α2,6- and α2,3-linkages; furthermore, the finding of 
α2,3-linked SAs in the human airway epithelium can explain the ability of viruses of avian 
origin to infect and replicate in humans, although not sufficiently enough to induce an 
efficient human to human virus transmission (Matrosovich et al., 1999). Neuraminidase is 
also involved in the interaction with host receptors; in particular, neuraminidase of avian 
origin prefers to hydrolyze the α2,3- rather than the α2,6-linked SA. The equilibrium between 
the two main surface glycoproteins HA and NA must be balanced to allow a perfect 
enzymatic activity and a functional viral replication. 
Pigs play a crucial role in influenza ecology and epidemiology, primarily because of their 
dual susceptibility to human and avian viruses. They possess both SA-α2,3-Gal-terminated 
saccharides and SA-α2,6-Gal-terminated saccharides in cells lining the trachea and are 
therefore considered a potential “mixing vessel” for influenza viruses, from which 
reassortants may emerge. The introduction of AI viruses to pigs is not an uncommon 
occurrence (Wagner et al., 2002). 
 Occasionally, infection of humans and other mammals by avian influenza viruses may 
occur (Capua and Alexander, 2008), which proves that the species barrier is not 
insurmountable. Some avian or swine influenza A virus subtypes (e.g. swine H1 and H3, 
avian H5, H6, H7, H9 and H10) have occasionally infected humans, without however 
establishing in human population. Previous studies have shown that the H7N9 subtype is 
probably the result of several reassortment events involving the subtype H9N2 and the 
subtypes H7 and N9, all of avian origin The avian H9 influenza virus subtype can also infect 
humans and cause a mild influenza-like illness (Butt et al., 2010). 
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Epidemiology of H9N2 avian influenza virus 
H9N2 subtype avian influenza viruses (AIV) have widely circulated in the world since its 
first detection in turkeys in Wisconsin in 1966 (Homme and Easterday, 1970). In North 
America, H9N2 viruses were mainly found in shore birds and wild ducks (Kawaoka et al., 
1988; Shaw et al., 2002) and no H9-associated disease was reported in chickens (Perez et al., 
2003). In Asia, H9N2 viruses were isolated regularly from ducks before the ‘90s (Shortridge, 
1992). However, infections of H9 subtype AIV in chickens have been reported in many Asian 
countries in chickens since later ‘90s (Alexander, 2000). 
H9N2 is enzootic in poultry across large areas of Asia, the Middle East, and North Africa 
where it imposes a large economic burden due to reduced growth rates in broilers and reduced 
fertility and egg production in breeders and layers. Although H9 viruses are classified as low 
pathogenicity avian influenza viruses (LPAI), mortality in the field of more than 50% has 
been recorded and there have been instances of field strains displaying a highly pathogenic 
phenotype both in the field and in the laboratory (Nili et al., 2003). 
The H9N2 viruses fall into a number of genetically defined lineages, with the majority of 
those circulating in Middle East and far East. Until now there is not a standard nomenclature 
system for the H9 subtype. Based on most reported genetic studies, two major lineages of 
H9N2 viruses have circulated in poultry and wild birds: North American and Eurasian. The 
Eurasian lineage is subdivided into two major sub-lineages: A/quail/Hong Kong/G1/97-like 
(G1-like) and A/duck/Hong Kong/Y280/97-like (Y280-like), both of which have become 
established in domestic poultry during the mid-1990s (Webster et al., 1992). 
H9N2 subtype viruses have been isolated from pigs in 1998 (Peiris et al., 1999a). 
Subsequently, they have been isolated from humans with influenza-like illness in Hong Kong 
and Mainland China (Guo et al., 1999; Peiris et al., 1999b). 
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The two human H9N2 isolates from Hong Kong belong to the G1 group, while at least 1 
human isolate from China and 2 isolates from pigs from Hong Kong are G9-like viruses (Guo 
et al., 1999; Lin et al., 2000). 
 
H9N2 AIV vaccination in poultry 
Vaccination is considered a promising control measure for H9N2 infection in poultry and 
has been adopted by many countries when the disease becomes endemic. The veterinary 
authorities in different countries (Iran, Korea, China) permitted the use of a single H9N2 
LPAI vaccine strain to simplify the evolution of the circulating virus due to the immune 
pressure caused by the vaccine use (Choi et al., 2010; Li et al., 2005; Vasfi Marandi et al., 
2013). 
An inactivated vaccine derived from an early isolate, A/chicken/Shandong/6/96 
(CK/SD/6/96), has been used in layers and breeders in chicken farms since 1998 (Li et al., 
2005). However, virus infection still occurred, sometimes even in vaccinated flocks and in 
recent years vaccine failure in many areas has become common due to the emergence of 
antigenic variants which harbour mutations in the major influenza antigen, hemagglutinin 
(HA). Consequently, efforts have been made to identify molecular markers in the HA gene 
that influence the antigenic diversity of H9N2 viruses leading to vaccine failure (Park et al., 
2011). 
Recently multiple introductions of a reassortant H5N1 avian influenza virus of clade 
2.3.2.1c with PB2 gene of H9N2 subtype has been identified in Indian poultry. The virus 
possesses the molecular signature of high pathogenicity for chickens, which is corroborated 
by intravenous pathogenicity index of 2.96. The virus is a reassortant which derives its PB2 
gene from H9N2 virus isolated in China during 2007-2013 (Tosh et al., 2016). 
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H9N2 avian influenza virus a pandemic potential 
In the last 20 years, novel non-seasonal influenza viruses have emerged in humans, most of 
which have originated from birds. In recent years, several novel reassorted influenza viruses 
(e.g. H7N9, H9N2, and H10N8) have jumped the host-species barrier and are monitored by 
the scientific community and public health systems. It is still unclear whether these viruses 
can actually cause pandemics or just isolated episodes (Trombetta et al., 2015). 
A significant proportion of H9N2 field isolates have acquired human virus-like receptor 
specificity, preferentially binding α2-6-linked sialic acid (SAα2-6) receptors, in contrast to the 
classic avian virus-like receptor specificity that preferentially binds α2-3-linked sialic acid 
(SAα2-3) receptors (Matrosovich et al., 2001). Interestingly, a few of the H9N2 viruses that 
recognize SAα2-6 receptors have transmitted directly to humans, causing mild flu-like illness. 
Domestic pigs have been confirmed as being infected with H9N2 influenza viruses, and 
infections have been reported also in swine along with other mammals in recent years. 
The first case of human infection from H9N2 avian influenza virus was reported in Hong 
Kong in 1999 and further human infections were reported in 2003. To date, different human 
cases of H9N2 AI infection have been reported by the World Health Organization (WHO); in 
2015 new cases in Egypt and Bangladesh have been described. Furthermore, H9N2 viruses 
can contribute with gene segments during reassortment events leading to the generation of 
novel avian influenza virus that can infect humans (e.g. recent Chinese H7N9 and H10N8 
viruses). Recent transmission studies have demonstrated that some natural isolates of H9N2 
viruses can acquire the ability to transmit efficiently among ferrets via respiratory droplets. In 
addition, it has been reported that serial passages of an H9N2 virus through guinea pigs can 
result in the introduction of amino acid substitutions, which increases contact transmission 
efficiency in this mammalian model. 
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The recurring presence of H9N2 infections in humans and mammals has raised concerns 
about the possibility of H9N2 viruses evolving into pandemic strains. 
 
H9N2 AI in Iran 
In Iran, there are 17,950 poultry farms with a yearly chicken meat production of 2 million 
tons (1.2 billion broilers and 14 million breeders) and a production of table eggs (40 million 
layers) amounting to 700,000 tons (data obtained from the Iran Veterinary Organization in 
2015). 
Since 1998, an epidemic of avian influenza occurred in the Iranian poultry industry. The 
identified agent presented low pathogenicity, and was subtyped as an H9N2 avian influenza 
virus. In broiler chicken farms the mortality was between 20% and 60%. Mixed infections of 
the influenza virus and other respiratory pathogens, particularly infectious bronchitis virus 
and Mycoplasma gallisepticum, were thought to be responsible for such high mortality, which 
resulted in great economic losses. Clinical signs included swelling of the periorbital tissues 
and sinuses, typical respiratory discharge, and severe respiratory distress (Nili et al., 2003). 
Unfortunately, despite the massive vaccination of breeder flocks, the H9N2 strains 
continued to circulate in nearly all provinces of Iran. The vaccines used for H9N2 infections 
in the Iranian poultry industry are produced by locally companies or imported from 
international pharmaceutical companies (Vasfi Marandi et al., 2013). 
Serological analysis of Iranian viruses revealed that the currently circulating strains are 
antigenically distinct from the vaccine strain. These results suggest that the commercial 
vaccine is not genetically and antigenically similar to the viruses currently circulating in the 
region. These findings also show that it is important to monitor the genetic and antigenic 
variations in H9N2 influenza viruses when selecting a vaccine strain (Bahari et al., 2015). 
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Recently, the association of high mortality and case report of H5N1 and H9N2 Iranian 
influenza virus in wild birds raised the possibility of a new genetic modified AI virus 
(Majidzadeh et al., 2011). 
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AIMS OF THE THESIS 
The impact of the H9N2 AI virus with respect to public health and poultry industry has 
been highlighted in the introduction section; however, it can be shortly reminded here that this 
zoonotic agent is responsible for disease in poultry resulting in serious and huge economic 
losses worldwide. The extent of the genetic reassortment involving H9N2 viruses, their ability 
to infect humans, and their continue circulation in domestic poultry and mammals emphasizes 
the potential for the emergence of a virus with the ability to adapt in the human population 
and cause the next influenza pandemic. Therefore, continue research and surveillance 
programs are required to monitor the presence of the H9N2 AIVs in poultry and humans, as 
well as to infer their evolutionary trends. Since the second half of the ’90s, outbreaks caused 
by H9N2 subtype have been reported in Iran and the continued presence of this subtype may 
mean that it is becoming an established endemic virus in this country. 
The research presented in this thesis (Chapter 2) aims to address important preliminary 
questions regarding the potential exposure to H9N2 AI viruses among Iranian (Fars province) 
poultry workers: evaluate the possibility of avian to human transmission of H9N2 AIVs; 
assess whether the human exposure to this influenza virus subtype occurred and whether the 
poultry operators in the Iranian endemic areas (Fars province, in this study) are at risk of 
exposure to the H9N2 infection. 
Another objective (Chapter 3) of the research project focuses on phylogenetic analyses of 
H9N2 AI viruses to provide a better understanding of the mechanisms underlying the 
evolutionary dynamics along with creation of a unified nomenclature system for the 
identification and classification of all the H9 subtypes. This would be beneficial to improve 
our capacity to identify effective target surveillance and potentially to predict evolutionary 
trajectory for appropriate selection of control strategies. The adoption of an internationally 
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accepted nomenclature is crucial for future studies of H9N2 virus epidemiology and 
evolution. 
Finally, the last aim (Chapter 4) is to apply the recently developed bioinformatics analyses 
to explore the phylogenetic evolution, virus introductions, and the presence of selection 
pressures of H9N2 viruses in an endemic country as Iran. 
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Abstract 
Background: Since the 1990s, influenza A viruses of the H9N2 subtype have been causing 
infections in the poultry population around the globe. This influenza subtype is widely 
circulating in poultry and human cases of AI H9N2 have been sporadically reported in 
countries where this virus is endemic in domestic birds. The wide circulation of H9N2 viruses 
throughout Europe and Asia along with their ability to cause direct infection in mammals and 
humans, raises public health concerns. H9N2 AI was reported for the first time in Iran in 1998 
and at present it is endemic in poultry. This study was carried out to evaluate the exposure to 
H9N2 AI viruses among poultry workers from the Fars province. 
Methods: 100 poultry workers and 100 healthy individuals with no professional exposure 
to poultry took part in this study. Serum samples were tested for antibodies against two 
distinct H9N2 avian influenza viruses, which showed different phylogenetic clustering and 
important molecular differences, such as at the amino acid (aa) position 226 (Q/L) (H3 
numbering), using haemagglutination inhibition (HI) and microneutralization (MN) assays. 
Results: Results showed that 17% of the poultry workers were positive for the 
A/chicken/Iran/10VIR/854-5/2008 virus in MN test and 12% in HI test using the titer ≥40 as 
positive cut-off value. Only 2% of the poultry workers were positive for the 
A/chicken/Iran/12VIR/9630/1998 virus. Seroprevalence of non exposed individuals for both 
H9N2 strains was below 3% by both tests. Statistical analyses models showed that exposure 
to poultry significantly increases the risk of infection with H9N2 virus. 
Conclusions: The results have demonstrated that exposure to avian H9N2 viruses had 
occurred among poultry workers in the Fars province of Iran. Continuous surveillance 
programmes should be implemented to monitor the presence of avian influenza infections in 
humans and to evaluate their potential threat to poultry workers and public health. 
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Background 
Most emerging diseases are of zoonotic origin, with wild and domestic animals acting as 
natural reservoirs (Kruse et al., 2004). Globalization and intensive animal farming have led to 
an increased spread of zoonotic infections (Cutler et al., 2010). Influenza type A viruses 
include several distinct subtypes based on the antigenic properties of the two major surface 
glycoproteins, the hemagglutinin (HA) and the neuraminidase (NA). To date, 18 subtypes of 
HA (H1-H18) and 11 subtypes of NA (N1-N11) have been described (Tong et al., 2013). 
A number of influenza A subtypes have successfully crossed the species barrier and have 
established in the mammals and human population, causing yearly seasonal epidemics or they 
have sporadically been directly transmitted from poultry to humans causing zoonotic 
infections (Riedel et al., 2006, Katz et al., 2009). The influenza A viruses of the H9N2 
subtype are classified as low pathogenic avian influenza (LPAI) viruses. They cause 
infections both in wild birds and in the poultry population worldwide, including several 
countries in Asia, Europe, North Africa and North America (Alexander et al., 2003, Brown et 
al., 2006). A significant proportion of recent H9N2 avian influenza (AI) isolates contains the 
L226Q (H3 numbering) amino acid substitution in their hemagglutinins (HAs) showing 
preferential binding to analogs of receptors with sialic acid linked to galactose by α2,6 linkage 
(SAα2,6Gal), a phenotypic portrait which is characteristic of human influenza viruses. Thus, 
these AI viruses might possess one of the key elements for infection in humans (Lin et al., 
2000, Ge FF. et al., 2009, Wan et al., 2007). Indeed, H9N2 viruses were isolated for the first 
time from humans in Hong Kong in 1999 and further human infections were reported in 2003 
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(Saito et al., 2001, Butt et al., 2005). These studies have shown that avian H9N2 viruses 
isolated from chickens are closely related to the H9N2 viruses responsible for human 
infection (Cameron et al., 2000). One human case of H9N2 AI was reported in Bangladesh 
(Shanmuganatham et al., 2013) and the World Health Organization (WHO) in 2015 has 
reported new cases in Egypt and Bangladesh (WHO June 2015, WHO September 2015). In 
1998, domestic pigs from Hong Kong were confirmed as being infected with H9N2 influenza, 
and infections have been reported also in recent years in swine along with other mammals 
(Peiris et al., 2001, Peng et al., 2015). Furthermore, H9N2 viruses can contribute with gene 
segments during reassortment events leading to the generation of novel avian influenza virus 
that can infect humans (e.g. recent Chinese H7N9 and H10N8 viruses) (Gao et al., 2013, 
Zhang et al., 2014). Recent transmission studies have demonstrated that some natural isolates 
of H9N2 viruses can acquire the ability to transmit efficiently between ferrets via respiratory 
droplets. In addition, it has been reported that serial passages of an H9N2 virus through 
guinea pigs can result in the introduction of amino acid substitutions, which increases contact 
transmission efficiency in this mammalian model (Li X, et al., 2014, Sang et al., 2015). 
The wide circulation of H9N2 viruses throughout Eurasia, along with their ability to cause 
direct infections in mammals and humans, raises public health concerns on their potential role 
as candidates for the next influenza pandemic (Li KS et al., 2003). H9N2 human infection is 
generally asymptomatic or responsible for mild clinical signs. This may explain the scarcity 
of evidence accounting for the circulation and transmission of this virus subtype (Liu et al., 
2013). Nonetheless, human sera positive for H9 subtype were identified in China, India, Iran, 
Thailand, Cambodia, Romania, Egypt and Pakistan (Wang et al., 2015, Pawar et al., 2012, 
Hadipour et al., 2011, Alizadeh et al., 2009, Anvar et al., 2013, Khuntirat et al., 2011, Blair et 
al., 2013, Coman et al., 2013, Gomaa, 2015, Ahad et al., 2014). 
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In Iran, the H9N2 subtype was identified for the first time in 1998 and is still circulating in 
the poultry population. In the affected farms the mortality rate ranges between 20 and 60%, 
although this may also be attributable to co-infections with other pathogens, such as IBV or 
Mycoplasma gallisepticum (Nili et al., 2003). In spite of the implemented national control 
measures, which include the mass vaccination of poultry, the virus has rapidly spread and can 
be considered endemic in the Iranian poultry (Vasfi et al., 2013). 
Exposure to H9N2 AI viruses in Iranian poultry workers was previously revealed by 
means of HI test, using serum titre ≥20 as positive cut-off (Alizadeh et al., 2009, Anvar et al., 
2013). In previous reported studies, the H9N2 AI seroprevalence, assessed by means of HI 
test, in Iranian poultry workers ranged from 1.6 to 15.7% (Median 9.5). Amongst the Middle-
Eastern and Southern Asia countries, the highest seroprevalence was observed in Pakistan 
(47.8%) by means of HI test (Ahad et al., 2014) and 7.5% by means of MN test in Egypt 
(Gomaa, 2015). In the present study, two different serological tests were used and compared 
to screen 200 individuals from the Fars province, Iran to better understand the risk of 
infection with the H9N2 virus in the poultry sector. The two different diagnostic tests were 
applied to assess whether (i) the human exposure to this virus subtype can be confirmed and 
whether (ii) the poultry operators in the Iranian endemic areas (the Fars province, in this 
study) are at risk of exposure to the H9N2 infection. 
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Methods 
Study population and sample collection 
The analyses were conducted on the blood sera of 100 workers regularly exposed to 
poultry (exposed group) and of 100 individuals with no professional exposure to poultry 
(unexposed group). The individuals, belonging to the exposed group, were recruited among 
the operators of the poultry industry and of the University Poultry Veterinary Hospital, none 
of whom had been vaccinated against flu. In particular, blood samples were collected between 
September – December 2012 from 70 slaughterhouse workers, 30 poultry house workers and 
from 10 operators of the University Poultry Veterinary Hospital, all resident in the Fars 
province (southern Iran). In January 2013, 100 sera were also collected from subjects from the 
same province not professionally exposed to poultry. 98% of the individuals included in the 
study were males, whose mean age among the poultry workers was of 32 years (ranging 
between 18–62). The mean age in the professionally unexposed group was of 41 years (range 
between 18–67). After blood collection the serum was separated, stored at –20 °C and 
subsequently sent to IZSVe for the serological analyses. 
Ethics statement 
The use of serum samples for research purposes was approved by the Veterinary 
University of Shiraz in compliance with the Iranian ethical principles and institutions and 
according to the principles expressed in the World Medical Association Declaration of 
Helsinki. Informed consent was obtained from all participating individuals. 
Selection of antigens and sera 
To select representative H9 antigens to be used in the serological investigations, the HA 
gene nucleotide and amino acid sequences of five Iranian H9N2 AIV isolates available at 
IZSVe repository were analysed and compared with the Iranian sequences available in the 
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GenBank. Subsequently, a nucleotide sequence dataset of 88 Iranian strains along with 
representative strains of G1 lineage were aligned and phylogenetically analysed constructing a 
Neighbour-Joining phylogenetic tree by the MEGA 5 (http://www.megasoftware.net) 
program (see results). In addition, sera of all individuals were tested for the presence of 
antibodies to seasonal A/Minnesota/ 11/2010 H3N2 and A/California/4/2009 H1N1pdm 2009 
viruses. Positive control sera containing antibodies directed against the selected H9N2 
antigens were produced in SPF chickens. In addition, a panel of different H9N2, H1N1, H3N2 
chicken sera and an H1N1, H3N2 positive human sera were used as controls in the serological 
assays. 
 
Serological methods 
Hemagglutinin inhibition (HI) test 
The HI assay was applied according to the World Health Organization (WHO) and World 
Organisation for Animal Health (OIE) manual (WHO Manual on Animal Influenza Diagnosis 
and Surveillance, OIE 2015 Chapter 2.8.8). Briefly, 0.5% (vol/vol) chicken red blood cell 
(RBC) solution was prepared by washing with Phosphate buffered saline (PBS) containing 
0.5% Bovine serum albumin (BSA) (Sigma). To remove non specific serum inhibitors, the 
human serum samples were treated with RDE (receptor destroying enzyme) (Sigma-Aldrich) 
that was reconstituted with 5 ml sterile distilled water. 50 μl of serum was added to 200 μl of 
RDE diluted to 100 ml with calcium saline, PH 7.2 and incubated overnight at 37 °C. Then 5 
vol of 1.5% sodium citrate were added then heated at 56 °C for 30 min to inactivate remaining 
RDE. The treated sera were tested by haemagglutination assay to verify the presence of non-
specific agglutination. After that the treated serum (50 μl of each one) was diluted in two-fold 
serial dilutions (1:10) with 25 μl PBS in 96-well V-bottom microtiter plates. Subsequently, 25 
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μl of virus antigens containing 4 HA units were added to the wells and incubated at room 
temperature (RT) for 30–45 min. 50 μl of 0.5% chicken RBCs were then added and the plate 
was incubated further for 45 min at RT before recording the agglutination titers. The HI test 
results were expressed as the reciprocal of the last dilution of the sample that completely 
inhibited haemagglutination. In all the assays control positive serum samples were included, 
and all assays were tested in triplicate. 
 
Microneutralization (MN) test 
The WHO MN test protocol was applied (WHO protocol of Serological diagnosis of 
influenza by microneutralization assay). The human serum samples were inactivated by 
heating at 56 °C for 30 min H9N2, H3N2 and H1N1pdm virus stocks used in our analyses 
were titrated in the presence of TPCK-trypsin (2 μg/ml) (Sigma-Aldrich) for determination of 
tissue culture infectious dose (TCID50). 10 μl of treated sera were added to 96 well cell 
culture plates (Costar) and 2-fold serial dilutions were performed. Inoculum was prepared in 
virus diluent with the addition of TPCK-trypsin (2 μg/ml) so that 50 μl contained 100 TCID50 
of the respective virus. Fifty microliters of virus inoculum was added to the wells, the virus 
serum mixture was subsequently incubated for 1 hr at 37 °C, 5% CO2. A back-titration of the 
virus inoculum was performed in each assay using 2 fold serial dilutions. 100 μl MDCK cells 
(1.5×104 cells /well) were then added to each well and the plate was incubated overnight at 37 
°C, 5% CO2 (18–20 hrs). The plate was then fixed with 100 μl/well of cold fixative (80% 
Acetone in PBS) for 10 min. The virus was detected with an anti-Influenza A, Nucleoprotein 
monoclonal antibody (Merck Millipore) and Peroxidase conjugated-goat anti-mouse IgG (γ) 
(KPL) as secondary antibody using ELISA. All serum samples and controls were tested in 
triplicate. 
  
 
38 
Criteria for seropositivity 
The WHO guidelines for vaccine evaluation suggest that a neutralizing antibody titre ≥40 
indicate higher than 50% protection against influenza A virus infection or disease. Based on 
this consideration, an individual with an antibody titer ≥40 was considered positive for 
different serotype in MN and HI tests (Eichelberger et al., 2007). 
 
Statistical Analyses 
The Geometric Mean titers (GMTs) of the triple test per method (HI and MN) was 
calculated for each subject checked for the virus of interest. A binary variable was created to 
identify the positive/negative sample. An average titre lower than 40 identified negative 
samples, whereas an average titre higher than 40 identified positive samples. The Chi square 
test was used to verify the possible association between positivity and exposure, for each 
method and virus. The GLM (Generalized linear model) for binary responses was used to 
estimate the probability to have a positive reaction for each tested virus, considering 
simultaneously the methods (HI and MN), the groups (exposed and unexposed) and their 
interaction as variables. The Maximum Likelihood method was used to estimate the 
parameters of the model. The Type III F-tests were applied to evaluate the overall effect of 
specified variables in the model. P-values lower than 0.10 were considered as significant 
(Dohoo et al., 2010) SAS 9.3 software was used to fit the statistical analysis.  
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Results 
The HA gene phylogenetic analysis of 88 Iranian H9N2 strains collected between 1998-
2014 shows that they belong to two different groups of G1 lineage, named sublineage A and 
sub-lineage B for the purpose of this study (Fig. 1). Sub-lineage A refers to the H9N2 isolates 
collected between 1998 and 2007, which apparently are no longer circulating among the 
Iranian poultry, while B includes more recent isolates collected between 2003 and 2014. The 
amino acid sequence analyses of the Iranian H9N2 viruses showed that sub-lineage A consists 
of 47% (14/30) of the strains with amino acid Q at position 226 (H3 numbering) and 53% 
(16/30) with L226 substitution. Interestingly, sub-lineage B encloses mostly (95%) (55/58) 
the strains with amino acid L226. Based on these results, two Iranian H9N2 isolates 
representatives of sub-lineages A (A/chicken/Iran/12VIR/9630/ 1998) and B 
(A/chicken/Iran/10VIR/854-5/2008) were selected as antigens for the serological study (Fig. 
1). In particular, A/chicken/Iran/12VIR/9630/1998 was characterized by the amino acid Q226 
while the A/chicken/ Iran/10VIR/854-5/2008 virus had amino acid L at this position. The HA 
amino acid sequence distance between the two selected strains was 8.1%. 
The percentage of seropositive individuals against different influenza viruses obtained 
with the HI and MN tests along with the p-value of the chi-square test related to the 
association between exposure and response to each virus tested, per method are reported in 
Table 1. Detailed results of serological investigations obtained for the exposed and unexposed 
groups against different influenza viruses are described in the Table 2. Serological results 
showed that the prevalence of antibodies against A/ chicken/Iran/12VIR/9630/1998 H9N2 (Q 
226) was of 2% in the exposed group by the HI and MN tests, while no positive results were 
identified in the unexposed group. 
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An association was observed between professional exposure to poultry species and the 
presence of antibodies to the A/chicken/Iran/10VIR/854-5/2008 H9N2 (L 226) virus, as 
revealed by the HI and MN test (p < 0.05). The percentage of positivity was of 12% for the 
exposed group and 2% for the unexposed group in the HI test, while it respectively amounted 
to 17% and 3% for the exposed and unexposed groups in the MN test. Antibody prevalence to 
H1N1pdm 2009 was of 28% in the exposed versus 53% in the unexposed groups by the HI 
test, and 25% versus 33%, respectively, by the MN test. For H3N2, the prevalence was 36% 
in the exposed group compared to 44% in the unexposed group with the HI test, while it was 
28% and 24% in the exposed and unexposed groups with the MN test. The titer distribution 
percentage against different viruses in different tests (Fig. 2) showed that with the increase of 
the titre range from ≥40 to ≥80 and from ≥80 to ≥160, the percentage of antibody positivity 
drastically decreased. Cross MN and HI tests on homologues and different chicken H9N2 
hyper immune sera used as positive controls showed the absence of cross reactivity with 
H1N1pdm 2009 and H3N2 seasonal viruses; the same results were observable in human 
immune sera for H1N1pdm 2009 and H3N2, which showed the absence of a cross reactivity 
with the two tested H9N2 viruses. 
The probability to be positive against A/chicken/Iran/ 10VIR/854-5/2008 H9N2, H3N2 
and H1N1pdm 2009 viruses in different tests was calculated. The generalized linear model for 
binary responses applied on the H9N2 viruses indicated that the association between 
professional exposure or absence of professional exposure and H9 infection was significant (p 
= 0.0018). In particular, the exposed and unexposed groups showed a significantly different 
positivity both in the HI test (9% vs. 1%) and in the MN test (13% vs. 2%). For the H3N2 
virus, the professional exposure was not significantly associated to the presence of antibodies 
(p = 0.22). This means that in both groups the probability of testing positive is almost similar. 
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Differently, the unexposed group showed a significantly higher number of individuals (p = 
0.001) seropositive to H1N1pdm 2009. If we consider that the H1N1pdm 2009 subtype does 
not circulate in avian species, it can be assumed that the serological data obtained for this 
subtype do not depend on the exposure to poultry species; other factors may have been at the 
origin of the distinct immunoreactivity observed against the H1N1pdm 2009 subtype in the 
two groups under study. 
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Figure 1. Neighbour-Joining Phylogenetic tree with 1000 bootstrap of the AI H9N2 HA gene 
of the G1 lineage. Sub-lineages A and B are highlighted with yellow and blue frames 
respectively, Iranian Sequences are highlighted in red and two Iranian strains used in 
serological analyses are highlighted with gray square. Numbers at the nodes represent 
bootstrap values (≥60). 
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 Triple test average (100 sample subjects) 
Virus 
HI MN 
% 
Positive 
% Positive 
p-
value 
% 
Positive 
% Positive 
p-value 
Exposed 
group 
Unexposed 
group 
Exposed 
group 
Unexposed 
group 
H9N2 
A/chicken/Iran/12VIR/9630/1998 
2 0 0.01 2 0 0.01 
H9N2 
A/chicken/Iran/10VIR/854-5/2008 
12 2 
0.00
5 
17 3 0.001 
H1N1pdm 2009 
A/California/4/2009 
28 53 
0.00
03 
25 33 0.02 
H3N2 
A/Minnesota/11/2010 
36 44 0.02 28 24 0.05 
 
Table 1. Positive titer percentages and p-value of the chi square test related to the association 
between exposure and response to each virus tested, per method. 
 
 
Figure 2. Graphic distribution of titer categories expressed in percentage among the subjects 
of the exposed and unexposed groups in the HI and MN tests. 
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Virus, Age group, Work 
group 
Subjects  HI MN 
Exposed 
subjects 
NO. 
Unexposed 
subjects 
NO. 
Positivity% in 
Exposed (subjects 
NO.) 
Positivity
% in 
Unexposed 
(subjects NO.) 
p-value 
Positivity% in 
Exposed (subjects NO.) 
Positivity% 
in Unexposed 
(subjects NO.) 
p-value 
H9N2 
A/chicken/Iran/12VIR/9630/1998 
        
Positive%         
Age group (Years)         
18-39 80 50 1 (1) 0 NS 1 (1) 0 NS 
40-60 20 50 5 (1) 0 0.1 5 (1) 0 0.1 
Work category         
Poultry House Worker 20 - 0 NO NO 0 NO NO 
Slaughterhouse Worker 70 - 1.43 (1) NO NO 1.43 (1) NO NO 
Vet Student in poultry Hospital 10 - 10 (1) NO NO 10 (1) NO NO 
Positive% ≥40 100 100 2 (100) 0 (100)  2 (100) 0 (100)  
Positive% ≥80 100 100 2 (100) 0 (100)  2 (100) 0 (100)  
Positive% ≥160 100 100 2 (100) 0 (100)  2 (100) 0 (100)  
TOT Positive% 100 100 2 (100) 0 (100) NS 2 (100) 0 (100) NS 
H9N2 
A/chicken/Iran/10VIR/854-5/2008 
        
Positive%         
Age (Years)         
18-39 80 50 13.7 (11) 2(1) 0.02 17.5 (14) 2 (1) 0.007 
40-60 20 50 5 (1) 2(1) NS 15 (3) 4 (2) NS 
Work category         
Poultry House Worker 20 - 5 (1) NO NO 15 (3) NO NO 
Slaughterhouse Worker 70 - 14.2 (10) NO NO 17 (12) NO NO 
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Vet Student in poultry Hospital 10 - 10 (1) NO NO 20 (2) NO NO 
Positive% ≥40 100 100 12 (100) 2 (100)  17 (100) 3 (100)  
Positive% ≥80 100 100 4 (100) 0 (100)  10 (100) 0 (100)  
Positive% ≥160 100 100 3 (100) 0 (100)  2 (100) 0 (100)  
TOT Positive% 100 100 12 (100) 2 (100) 0.005 17 (100) 3 (100) 0.001 
H1N1pdm 2009 
A/California/4/2009 
        
Positive%         
Age (Years)         
18-39 80 50 35 (28) 48(24) NS 30 (24) 28(14) NS 
40-60 20 50 0 (0) 58(29) <0.0001 5 (1) 38(19) 0.005 
Work category         
Poultry House Worker 20 - 40 (8) NO NO 40 (8) NO NO 
Slaughterhouse Worker 70 - 27 (19) NO NO 23 (16) NO NO 
Vet Student in poultry Hospital 10 - 10 (1) NO NO 10 (1) NO NO 
Positive% ≥40 100 100 28 (100) 53 (100)  25 (100) 33 (100)  
Positive% ≥80 100 100 1 (100) 36 (100)  6 (100) 7 (100)  
Positive% ≥160 100 100 0 (100) 12 (100)  0 (100) 1 (100)  
TOT Positive% 100 100 28 (100) 53 (100) 0.0003 25 (100) 33 (100) NS 
H3N2 
A/Minnesota/11/2010 
        
Positive%         
Age (Years)         
18-39 80 50 41 (33) 46 (23) NS 32 (26) 24 (12) NS 
40-60 20 50 15 (3) 42 (21) 0.03 10 (2) 24 (12) NS 
Work category         
Poultry House Worker 20 - 40 (8) NO NO 20 (4) NO NO 
Slaughterhouse Worker 70 - 35 (25) NO NO 32 (23) NO NO 
Vet Student in poultry Hospital 10 - 30 (3) NO NO 10 (1) NO NO 
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Positive% ≥40 100 100 36 (100) 44 (100)  28 (100) 24 (100)  
Positive% ≥80 100 100 28 (100) 25 (100)  7 (100) 11 (100)  
Positive% ≥160 100 100 8 (100) 14 (100)  2 (100) 4 (100)  
TOT Positive% 100 100 36 (100) 44 (100) NS 28 (100) 24 (100) NS 
 
Table 2. Results of serological investigations obtained for the different categories of exposed and unexposed groups against different influenza 
viruses. NS: not significant, NO: No data.
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Discussion and conclusion 
Results demonstrated that exposure to avian H9N2 viruses had occurred in humans in Iran 
(Fars province). In particular, the analysis showed a significantly higher prevalence of 
neutralizing antibodies against the A/chicken/Iran/10VIR/854-5 H9N2 virus in poultry 
workers than in the professionally unexposed group. These results are in accordance with a 
previously reported study from Iran by Alizadeh et al., 2009 confirming that poultry workers 
are at risk of infection from zoonotic avian influenza virus. For the first time in this study, two 
distinct H9N2 LPAI viruses were used as antigens for serological investigations in humans. 
Interestingly, neutralizing activity against just one of these two antigens was revealed in 
several sera, which has resulted in significant different prevalence. This is consistent with the 
amino acid diversity of the two H9N2 antigens used in this study. In fact, the HA amino acid 
sequences of A/chicken/Iran/12VIR/ 9630/1998 (Q-226) and A/chicken/Iran/10VIR/854-5/ 
2008 (L-226) differed for 43 amino acids, seven of which were located in antigenic sites 
(S158N, S160L, S175D, E190A, S193N, N208D, Q226L (H3 numbering)) previously 
reported by other groups (Kaverin et al., 2004, Zhu et al., 2015, Okamatsu et al., 2008, 
Yasugi et al., 2013). These amino acid substitutions may account for the different serological 
reactivity against these antigens. However, the difference in prevalence observed in this study 
between two tested H9N2 viruses might have different explanations. 
The receptor binding properties of A/chicken/Iran/ 12VIR/9630/1998 H9N2 (Q-226)-like 
viruses affect their ability to infect humans. As a consequence, the infections of this virus in 
the exposed population are limited. On the contrary, the A/chicken/Iran/10VIR/854-5 H9N2 
(L-226) – like viruses, have increased ability to infect humans resulting in higher prevalence 
in the exposed population. However, it should be considered that the molecular analysis of 
Iranian H9N2 viruses demonstrated that those harbouring the Q-226 mutations apparently are 
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no longer in circulation. Furthermore, one previous study investigating the serologic response 
in humans exposed to avian viruses concluded that the incidence of seroconversion is low and 
that the antibody response after mild/asymptomatic infections is short-lived (Eichelberger et 
al., 2007). Therefore, the reduction of the circulation of Q-226 viruses in the poultry in recent 
times and/or the low antibody response after infection might be responsible for the decreased 
prevalence of antibodies against these AI viruses. 
Consistently with the results discussed so far, the unexposed group counting 100 healthy 
subjects showed a very low percentage of positivity for H9N2 by the HI and MN tests, while 
the distribution of positive titres against H1N1pdm 2009 and seasonal H3N2 influenzas were 
similar in the exposed and in the unexposed groups. 
According to Stephenson et al., 2003 the cross reacting antibodies against H2 might 
explain the antibody reactivity against avian H9N2, especially among people born before 
1968. Although we did not test the sera for this antigen, to evaluate this hypothesis, the age of 
each individual who had tested H9 positive was verified. Only one sample was from a person 
born before 1968, while all the others were collected from younger subjects with an age 
between 22-46 years, who could not be positive for H2N2. 
The comparison between the serological results obtained using the HI and MN tests 
against H9N2 showed that the MN test detected more positive samples within the same group, 
however, the triple test results proved that the HI titer was reasonably more consistent than 
the MN test. In addition, different researches have reported that intra-laboratory 
reproducibility by MN is lower than the one resulting from the HI test (Stephenson et al., 
2009), a fact that may explain the moderate discrepancy observed between the two serological 
assays applied for the detection of antibodies against H1N1pdm 2009 and H3N2 seasonal 
influenza. Both in the HI and MN tests, the percentage of positivity for H9N2 decreased with 
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the increase of the titre range; the obtained results were justified on the grounds that humans 
have a poor immune response to infections with avian influenza viruses. For instance, studies 
have shown that the individuals with mild or asymptotic infections had a lower antibody titer 
compared to individuals who had seriously developed the illness (Buchy et al., 2010). H9N2 
AI viruses have some of the specific molecular markers for the infection of mammals; 
however, they are still unable to completely adapt to mammals and to cause serious disease in 
humans, which may explain the low titers observed. As well, the time elapsed between the 
infection and sampling dates can also account for the decrease of the antibody titer. 
In conclusion, this study has highlighted the potential of avian to human transmission of 
H9N2 AIVs, and indicated that poultry workers are at risk of infection. Avian transmission of 
H9N2 viruses in humans can increase the probability of human adaption, while genetic 
reassortment with other human seasonal viruses are means of generating an influenza virus 
with epidemic or pandemic potential. Hence, integrated medical-veterinary surveillance and 
research activities are essential in order to identify the emergence of new influenza viruses, 
assess the clinical significance of seropositivity and understand more on the mechanisms that 
favour the virus to cross the species barrier. In the poultry sector, surveillance and control 
programmes should be implemented to reduce the prevalence of H9N2 AIV in poultry 
population and minimize the risk of exposure in poultry operators.  
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Abstract 
Influenza A virus is a zoonotic agent with a significant impact both on public health and 
poultry industry and avian influenza H9N2 virus provided the records of switch to human 
host. Therefore, surveillance and characterization are needed by the scientific community and 
public health systems and so far this was mainly based on intensive serological 
characterization and phylogenetic analyses aimed to infer evolutionary trends. In order to aid 
molecular epidemiologic assessment and support public health interventions, as well as to 
properly relate investigations worldwide thanks to shared nomenclature and robust guidelines, 
we developed a method for the clade nomenclature of all AI H9N2 hemagglutinin subtypes, 
based on the evolutionary dynamics of a large and non redundant viral strain dataset. This was 
combined to a phylogeographic analysis providing further information on the spatiotemporal 
evolution, correlation and spreading of H9N2 viruses from the beginning to current trends. 
We found that H9N2 viruses can be clustered in five classes based on congruence of 
phylogenetic and phylogeographic data with structural comparison evidence. Structural 
analyses can properly depict structural closeness among proteins or protein domains and 
provide functional insights on surface regions possibly crucial to antigenicity and cell binding. 
Recent successful inference of surface feature fingerprints for H5N1 evolution prompted us to 
assess whether such fingerprints are peculiar to H5N1, or electrostatic variation could be 
associated to the evolution and spreading of other avian influenza viruses, e.g. the newly 
defined classes and clades from the H9N2 subtype. 
Finally, surface feature fingerprints could be inferred that relate class and clade specific 
variation in electrostatic charges and isocontour to well-known hemagglutinin sites involved 
in modulation of immune escape and host specificity. Results from this work suggest the 
integration of up-to-date phylogenetic and phylogeographic analyses with sequence-based and 
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structural investigation of surface features as a front-end strategy for inferring trends and 
relevant mechanisms in influenza virus evolution. 
 
Running Head: Phylogenetic-bioinformatic study of H9N2 evolution. 
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Background 
Influenza A virus is a zoonotic agent with a significant impact both on public health and 
poultry industry. Wild waterfowl are primary reservoirs of avian influenza viruses (AIV) that 
in addition to birds can sporadically infect mammalian hosts including humans. This is 
suggestive for setting up a coordinated global surveillance network (Butler, 2012) as well as 
for studying viral evolution. Indeed, improving the capacity to monitor viral genetic changes 
to predict 'evolutionary trends' can be crucial to boost surveillance, especially when 
considering those viral clades for which is reported or likely to occur avian to 
mammals/humans host switch (Al-Tawfiq et al., 2014). In addition to viral strains with well 
known potential to jump the host-species barrier (Nelson and Vincent, 2015), further risk for 
human and animal health depends on the emergence of novel reassortant viruses, especially in 
those regions where multiple strains and clades are known to co-circulate (Su et al., 2015). 
Avian influenza (AI) viruses from the H5N1 subtype are unique in their ecological success, 
showing extremely broad host range and geographical spreading (Guan and Smith, 2013). 
Therefore, based on intensive phylogenetic analyses just for H5N1 clades and subclades a 
standard nomenclature was published (WHO/OIE/FAO H5N1 Evolution Working Group, 
2008; Guan and Smith, 2013) and it is actually adopted by the scientific community. General 
concern for pandemic risk decreased after the peak of the H5N1 virus, but indeed novel 
reassorted subtypes (e.g., H7N9, H9N2, H10N8) jumped in recent years the host-species 
barrier and thus surveillance and characterization are needed by the scientific community and 
public health systems (Trombetta et al., 2015). In particular, the isolation of H9N2 virus from 
two Hong Kong children seems to be the first record of switch to human host (Peiris et al., 
1999); then, these viruses could occasionally be transmitted from poultry to humans and other 
mammals (Lin et al., 2000; Butt et al., 2005; Sang et al., 2015). 
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Even though host jump and pandemic influenza phenomena raised much attention to AI 
viruses because of their potential impact on human health, studying virus variation related to 
either low to high-pathogenicity shift or to antigenic drift is needed as well, as it is quite 
relevant to animal health and of special impact on poultry industry and vaccine efficacy. In 
fact, outbreaks of high pathogenic AI (HPAI) can result in killing hundreds millions poultry 
and wild birds in tens of countries (Swayne, 2012). This makes proper vaccination strategies 
(at least in poultry animals) crucial to prevent wide mortality and in turn viral variation 
potentially resulting in antigenic drift becomes a factor to be monitored in that associated to 
risk of impairing vaccine efficacy. 
Evolution and spread of low pathogenic AI (LPAI) and HPAI viruses, belonging to H5, 
H7 and H9 subtypes, amongst birds and their sporadic infection in humans continues to 
represent a great concern for public health (Lin et al., 2000). Therefore, these avian subtypes 
are included as top pandemic agents in the list from the World Health Organization (WHO). 
To date, only H5 and H7 subtypes of influenza A viruses were reported to evolve from a 
LPAI to HPAI form after their introduction into poultry from the wild bird reservoir 
(Alexander 2007). Both H5 and H7 viruses are notifiable to the Office International des 
Epizooties (OIE) because of the risk of LPAI becoming HPAI by mutation. H7 LPAI virus 
usually causes mild respiratory disease and a production decrease in infected poultry; its 
evolution into a HPAI form results in the generation of a virus able to cause severe disease 
and death in the poultry population  
(http://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/2.03.04_AI.pdf). 
One example assessing the ability of LPAI to evolve into HPAI form is the H7 avian 
outbreaks that affected Northern Italy between 1999 and 2001. Epidemiological information 
sustained by phylogenetic analysis, and deep sequencing approaches helped to reveal that 
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HPAI strains evolved from the LPAI viruses and that both lineages shared a common ancestor 
(Monne et al., 2014). 
Current AI vaccines are based upon the elicitation of a neutralizing antibody (Ab) 
response against the major epitope regions of the viral surface glycoprotein, hemagglutinin 
(HA). However, mutations in immune-dominant regions on the HA structure may result in 
antigenic drift allowing the virus to escape Ab neutralization (Velkov et al., 2013). Indeed, 
antigenic and genetic differences in HA and the other surface spike protein neuraminidase 
(NA) provide a rationale for classification of influenza type A virus subtypes: for instance, 
H9N2 viruses combine the H9 subtype HA with N2 subtype NA. Haemagglutinin plays a 
central role in influenza A virus evolution because it is crucial to the attachment and 
penetration into the host cell and as the main viral surface antigen it is also a major player in 
the stimulation of the neutralizing Ab response (Velkov et al., 2013). 
In this work, genetic diversity of H9N2 subtype was assessed through large-scale 
phylogenetic analysis; this resulted in a novel and updated classification scheme based on the 
phylogenetic topology and evolutionary distances following the same WHO standards for 
virus classification as for H5N1. Classic, sequence based phylogenetic analyses can be 
integrated by structural bioinformatic investigations that more properly depict structural 
closeness among proteins or protein domains. Indeed, we previously inferred molecular 
fingerprints for H5N1 evolution, as intriguing surface charge redistribution at the surface of 
the receptor binding domain (RBD) subregion of HA was found to relate to branching of still 
circulating clades 2 and 7 with respect to those ones that are no longer circulating (Righetto et 
al., 2014). This prompted us to assess whether such fingerprints are peculiar to H5N1, or 
electrostatic variation could be associated to the evolution and spreading of other AI viruses, 
e.g. the newly defined clades and subclades from the H9N2 subtype. 
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Methods 
Phylogenetic analyses 
HA gene nucleotide sequences of H9N2 subtype were retrieved from the Global Initiative 
on Sharing Avian Influenza Data (GISAID) EpiFlu database (http://www.gisaid.org). 
Nucleotide sequences of at least 1500 bp length were selected. 
 Multiple sequence alignment of HA sequences was performed with MAFFT version 7 
(http://mafft.cbrc.jp/alignment/server). Redudant isolates with 100% sequence similarity (i.e., 
redundant sequences) were identified and removed, giving a final HA dataset and alignment 
of 2842 sequences from 1960 to 2015 was subjected to phylogenetic trees reconstruction. The 
NJ, ML and Bayesian methods were used to construct three different phylogenetic trees for 
comparison. Analysis of the best-fit substitution model was performed using MEGA5 
(Tamura et al., 2011), and the goodness-of-fit of each model was measured by Bayesian 
Information Criterion and corrected Akaine Information Criterion (AICc). The General Time 
Reversible (GTR) model with a discrete gamma distribution (+Γ) allowing for invariant sites 
(+I) was selected based on AICc and used in all data analyses. MEGA5 was also used to 
perform phylogenetic analysis and the evolutionary history was inferred by both NJ and ML 
methods (Tamura and Kumar, 2002), with standard errors being calculated based on 1000 
bootstrap replicates. Furthermore, PhyML (version 2.4.4) (Guindon et al., 2003) was used to 
create ML trees. The GTR + Γ + I model of nucleotide substitution was used for the analysis, 
with an estimated gamma shape parameter. Robustness of the groups was assessed using the 
bootstrap approach with 100 replicatest. Bayesian phylogenetic tree was inferred using 
MrBayes software (Ronquist and Huelsenbeck, 2003) and applied to generate the dendrograms 
as well as to assess statistical supports for the branches from the trees generated by the 
original dataset. For ease of display, and also to ensure that the clade topology would be 
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maintained when fewer isolates are used, a small representative dataset of 360 H9N2 HA 
sequences was created and analyzed by the same aforementioned phylogenetic models. 
Phylogenetic trees were visualized using FigTree version 1.3.1 
(http://tree.bio.ed.ac.uk/software/figtree/). 
 The largest HA gene dataset alignment (n = 2842; length ≥ 1500 bp) used for the 
phylogenetic reconstruction, was also used to infer evolutionary distances (within and 
between groups) by pair-wise analysis. The number of base substitutions per site was 
calculated by two different methods. The simplest one (uncorrected pairwise distance) was 
performed by averaging all sequence pairs between groups, while the second method followed 
the Maximum Composite Likelihood model. Variation rate among sites was modelled with a 
Γ distribution value = 9.4 (calculated by preliminary estimation from our dataset) and the 
differences in the composition bias among sequences were considered in the evolutionary 
comparisons. The C-value ratio used in the H9N2 clades partitioning i.e. the ratio of the 
average pairwise distance between a particular taxon and its closest neighboring group 
divided by the average pairwise distance within that selected clade was used to confirm the 
clades partitioning. 
 
Bayesian phylogeography reconstruction 
Time-scaled phylogenies of H9N2 HA were inferred by Bayesian Markov chain Monte 
Carlo (MCMC) method implemented in BEAST v1.8.0 (Drummond et al., 2005) using the 
SRD06 codon position model and the uncorrelated log-normal relaxed clock model under a 
Bayesian skyline coalescent tree prior to the MCMC simulations (Jin et al., 2014). Spatial 
location reconstruction and viral migration were estimated using the discrete Bayesian 
phylogeographic method that utilised a continuous time Markov Chain over discrete sampling 
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locations, and applied a Bayesian stochastic search variable selection model (Lemey et al., 
2009). For our data set we performed four independent runs for 300 million generations with 
sampling every 30000 steps. Convergence and effective sampling size of estimates were 
assessed by visual inspection using Tracer v1.6 (http://beast.bio.ed.ac.uk/Tracer). Multiple 
chains were then combined after a 10% burn-in using LogCombiner v1.8.0 included in the 
BEAST package. The maximum clade credibility (MCC) tree with temporal and spatial 
annotation were summarized with a 10% burn-in removed using TreeAnnotator v1.8.0 in the 
BEAST package and presentation figures were generated using FigTree v1.4.2 
(http://tree.bio.ed.ac.uk/software/figtree/). 
We also conducted Bayes factor (BF) tests to provide statistical support for transmission 
routes between different geographic locations using SPREAD v1.0.6 with cutoff BF = 3 
(Bielejec et al., 2011). BF values represent the difference between the posterior and prior 
probabilities that the rates between two locations are non-zero. Thus, routes with high BF 
have large odds that a migration exists between two locations. 
To animate viral dispersal over the time, we converted annotated MCC trees into a keyhole 
markup language file using SPREAD v1.0.6, which can be visualized by Google Earth 
(http://earth.google.com) website platform. 
 
Structural Modeling and surface analysis 
Structural models for HA1 and RBD regions of target HA proteins were obtained by 
homology modelling as reported (Righetto et al., 2014) on best available structure templates 
using SWISS-MODEL (Bordoli et al., 2009). In particular, as a template for H9N2 HAs the 
currently available solved HA structure PDB 1JSH belonging to A/swine/Hong Kong/9/98 
(H9N2) was used. Refinement of model structures was performed using three independent 
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methods as reported (Righetto et al., 2014) and model quality was checked via QMEAN 
server (Benkert et al., 2009). Protein structures were viewed using UCSF Chimera (Pettersen 
et al., 2004) v. 1.10.2 (free download from http://www.cgl.ucsf.edu/chimera/). 
Comparative analysis of electrostatic potentials was performed as reported (Righetto et al., 
2014), simulating physiological conditions, i.e. the spatial distribution of the electrostatic 
potential was calculated at ionic strength (I) = 150 mM, assuming +1/-1 charges for the 
counter-ions. Isopotential contours were calculated using UCSF Chimera, which allows for 
connecting through Opal web server to the Adaptive Poisson-Boltzmann Solver server 
(http://www.poissonboltzmann.org/apbs). PDB2PQR was used to assign partial charges and 
van der Waals radii according to the PARSE force field (Sitkoff et al., 1994). Electrostatic 
distance was calculated using the Carbo index at the WebPIPSA server 
(http://pipsa.eml.org/pipsa). Rigid-body superposition was performed and electrostatic 
potential was computed using UCSF Chimera 1.10.2. For more details please see the methods 
section from Righetto et al., 2014.  
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Results 
Phylogenetic analysis and novel classification scheme for AI H9N2 HA 
Since the established classification system for AI virus subtypes is based on antigenic and 
genetic differences in the two surface spike proteins, we assessed the genetic diversity of the 
HA gene to develop a unified nomenclature and classification system for AI H9 subtype 
genetic groups. However, given that in the different classifications there is a stronger 
correlation between the phylogenetic topology and the evolutionary distances within and 
between genetic groups, we used the genetic correlation as the base to develop objective 
criteria to classify strains and create a definitive unified nomenclature. The classification 
criteria were determined based on the phylogenetic topology and on specific evolutionary 
distances that reflect the diversity of the AI H9N2 subtype. In order to get robust validation 
for phylogenetic analyses, the evolutionary history of 2842 AI H9N2 strains was inferred for 
HA nucleotide sequences ≥ 1500 bp using three different algorithms: neighbor-joining (NJ), 
maximum likelihood (ML) and Bayesian; when the evolutionary history was inferred from a 
smaller dataset alignment (360 strains), this confirmed consistency of the proposed 
classification. 
Figure 1 shows the nucleotide ML phylogenetic tree with the proposed grouping, while the 
full tree is depicted in Supplementary figure S1: the AI H9N2 strains clearly separate into five 
different cetelyhponom groups hereafter referred to as class A, B, C, D, and E. Within such 
classes, twenty-seven clades identified by numbers are separated based on inter-clade average 
distance ≥5% and intra-clade average distance <5% (Table 1) and separation for each 
identified clade is confirmed by C-value ≥ 1 (Table 2). Classes and clades were assigned 
when at least three isolates with different epidemiological history formed a distinct taxonomic 
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group with bootstrap value at the defining node ≥60%. Clades separation based on distance 
value cut off was confirmed using two different calculation algorithms (see methods). 
Fixed guidelines for classification are resumed in Table 3; circulation data and representative 
H9 subtype viruses used for different analyses performed in this work are listed in 
Supplementary table S1 to facilitate the interpretation of relationship to the proposed 
numbering system. 
When comparing intra-class nucleotide distance values, class A shows the highest genetic 
heterogeneity with a value up to 18.3%, whereas this value is around 10-11% in classes B and 
C. Class D just contains three strains isolated in Malaysia and class E only a few strains 
isolated mostly in the USA. Therefore, separate clades were not defined for the latter two 
classes. Few different strains that are no longer circulating and do not group within any 
identified class are considered as ancestral (black sequences in figure 1). Such topology 
distribution and grouping was fully confirmed when performing phylogenetic analysis with 
corresponding protein sequences (data not shown). 
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Figure 1: Maximum-likelihood trees of 360 H9N2 isolates constructed by PhyML. The 
different classes and clades are color coded. Estimates of the statistical significance of 
phylogenies were calculated by performing 100 bootstrap replicates. Numbers in the tree 
nodes represent the bootstrap support (≥60). 
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Figure S1: Maximum-likelihood trees of 2842 H9N2 isolates constructed by PhyML. The 
different classes and clades are color coded. Estimates of the statistical significance of 
phylogenies were calculated by performing 100 bootstrap replicates. Numbers in the tree 
nodes represent the bootstrap support (≥60). 
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C.1 7 8.1 8.2 6.8 * [0.6] [0.7] [0.7] [0.6] [0.6] [0.7] [0.6] [0.7] [0.6] [0.6] [0.6] [0.9] [0.9] [0.7] [0.7] [0.8] [0.8] [0.7] [0.8] [0.8] [0.8] [0.7] 
B.2.7 10.6 11.2 11.6 9.9 9.7 * [0.4] [0.4] [0.6] [0.5] [0.5] [0.4] [0.6] [0.6] [0.6] [0.6] [0.9] [0.8] [0.7] [0.7] [0.9] [0.8] [0.8] [0.8] [0.9] [0.9] [0.8] 
B.2.6 11.2 11.9 11.4 10.3 10.3 5.9 * [0.5] [0.6] [0.6] [0.5] [0.5] [0.6] [0.6] [0.6] [0.7] [0.8] [0.8] [0.7] [0.7] [0.8] [0.7] [0.7] [0.7] [0.8] [0.9] [0.7] 
B.2.5 9.8 10.6 10.9 8.9 9.2 5.6 5.8 * [0.6] [0.5] [0.5] [0.5] [0.5] [0.6] [0.6] [0.6] [0.9] [0.9] [0.7] [0.7] [0.8] [0.7] [0.7] [0.8] [0.8] [0.8] [0.7] 
B.2.4 11.5 11.4 12.1 10.6 10.2 7.3 7.3 7 * [0.5] [0.5] [0.5] [0.6] [0.6] [0.5] [0.6] [0.9] [0.9] [0.8] [0.7] [0.8] [0.7] [0.7] [0.8] [0.8] [0.8] [0.7] 
B.2.3 10.7 11.5 12 10.1 10.2 6.7 6.6 5.9 6.9 * [0.6] [0.5] [0.6] [0.6] [0.6] [0.6] [0.8] [0.8] [0.7] [0.6] [0.8] [0.7] [0.7] [0.7] [0.8] [0.8] [0.7] 
B.2.2 10.6 11.5 11.6 10.1 10.3 7.1 7.3 6.9 7.6 7.1 * [0.5] [0.6] [0.6] [0.6] [0.6] [0.9] [0.9] [0.7] [0.7] [0.8] [0.7] [0.7] [0.8] [0.9] [0.7] [0.7] 
B.2.1 9.7 10.3 10.7 8.7 8.7 5.4 5.7 6 6.1 5.8 6.4 * [0.6] [0.5] [0.5] [0.6] [0.9] [0.9] [0.7] [0.7] [0.8] [0.7] [0.7] [0.8] [0.8] [0.8] [0.7] 
B.4 8.7 9.8 9.9 7.8 7.6 7.4 7.8 6.7 8 7.6 8 6.1 * [0.5] [0.4] [0.6] [0.9] [10] [0.8] [0.8] [0.9] [0.8] [0.8] [0.8] [0.9] [0.9] [0.8] 
B.1.2 8.8 9.5 9.5 7.5 7.5 7.7 8.1 7.4 8.5 8.1 8.1 6.6 6 * [0.4] [0.5] [0.9] [0.9] [0.7] [0.7] [0.7] [0.7] [0.7] [0.7] [0.8] [0.8] [0.7] 
B.1.1 8.5 9.5 9.9 7.6 7.2 7.3 7.6 7 7.9 7.5 7.8 6.1 5.4 5.4 * [0.5] [0.9] [0.9] [0.7] [0.7] [0.8] [0.7] [0.7] [0.8] [0.9] [0.9] [0.7] 
B.3 9.9 11.1 11.5 9.3 9.2 8.6 9.3 8.7 9.6 9.2 9.4 7.8 6.6 6.5 6.4 * [0.9] [10] [0.7] [0.7] [0.8] [0.8] [0.8] [0.8] [0.9] [0.8] [0.8] 
A.1 13.3 14 15.2 13.9 14.5 15.4 15.3 15 15.9 15.3 15.5 14.9 14.2 14.7 14.1 15.4 * [0.9] [0.8] [0.8] [0.9] [0.9] [0.9] [0.9] [0.9] [10] [0.8] 
A.2 14.5 15 15.2 14.2 13.7 15.3 15.8 15.6 16.3 15.9 15.3 15.2 14.8 14.6 14.3 15.5 13.1 * [0.8] [0.9] [0.9] [0.8] [0.9] [0.9] [10] [0.9] [0.9] 
A.3 12.3 12.5 12.4 11.5 11.2 13.8 14.5 13.2 14.6 14 14.2 13.2 12.3 12.4 12.5 13.4 12.3 12.1 * [0.5] [0.6] [0.6] [0.6] [0.6] [0.7] [0.8] [0.6] 
A.4 10.6 11.2 11.9 10.3 9.9 12.6 13 11.8 12.7 12.3 12.5 11.4 10.6 10.7 10.6 11.8 12.2 12.1 7.4 * [0.6] [0.7] [0.6] [0.6] [0.8] [0.7] [0.7] 
A.5.1 12.5 13 13.3 12.5 11.9 14.3 14.6 13.9 14.2 13.9 14.1 13 12.8 12.5 12.9 14 13.9 12.5 9.8 8.4 * [0.7] [0.6] [0.5] [0.6] [0.8] [0.7] 
A.5.2 13.1 12.9 13.5 12.1 11.1 14.2 14.4 13.9 14.3 14.1 14.2 13.7 12.9 12.7 12.9 14.1 13.5 12.8 10.6 9.1 9.4 * [0.6] [0.6] [0.7] [0.8] [0.7] 
A..5.3 12.8 13.4 13.5 12.4 11.6 13.9 13.9 13.2 14.1 13.8 13.6 12.9 12.8 12.2 12.3 13.6 12.6 12.3 9.1 8.3 8 8.3 * [0.5] [0.6] [0.8] [0.7] 
A.5.4 12.3 12.7 12.6 12 11.2 13.7 14.2 13.5 14.1 13.8 13.5 12.7 12.5 12.3 12.3 13.3 12.6 12.4 8.7 7.6 7.1 7.6 5.4 * [0.6] [0.8] [0.6] 
A.5.5 13.1 13.3 13.7 12.6 12.2 14.7 14.6 13.8 14.7 14.2 14.8 13.5 13.3 12.8 13.1 14 14.3 14.4 11.2 9.9 9.7 10.4 9.1 8.5 * [0.9] [0.7] 
D. 12.3 12.3 13.2 11.6 11.4 14.1 14.2 12.9 13.6 13.5 13.5 12.8 11.8 11.8 11.4 12.8 15.2 13.4 11 9.5 12.5 12.7 12 11.6 13.7 * [0.8] 
E. 11.5 11.6 12.1 10.9 10.3 12.9 13.2 12.6 13.3 12.9 12.8 12 11.1 10.8 11 11.8 13.3 11.9 9.3 8.4 9.9 11.1 10 9.5 11.8 9.9 * 
Table 1: Estimates of evolutionary distances between H9N2 identified clades. Evolutionary distances (calculated by p-distance) between 
identified clades were calculated using 2842 nucleotide HA sequences ≥ 1500 bp in lenght. Max/min evolutionary distance values within classes 
A, B and C are highlighted in respectively red and blue colors. Values between brackets are standard errors, obtained by a bootstrap procedure 
(500 replicates). 
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clades APD Within 
Closest 
clade 
APD between 
clade & closest 
clade 
C-Value 
C.2.3 2.5 [0.3] C.2 6 2.4 
C.2.2 4.1 [0.2] C.2.3 6.3 1.5 
C.2.1 3.3 [0.2] C.2 6.1 1.8 
C.2 4.7 [0.2] C.2.3 6.7 1.4 
C.1 1.2 [0.1] C.2 6.8 5.6 
B.2.7 3.8 [0.2] B.2.5 5.5 1.4 
B.2.6 4.6 [0.3] B.2.1 5.7 1.2 
B.2.5 3.4 [0.2] B.2.7 5.4 1.5 
B.2.4 4.9 [0.3] B.2.3 6.9 1.4 
B.2.3 2.7 [0.2] B.2.5 5.9 2.1 
B.2.2 4.4 [0.2] B.2.1 6.4 1.4 
B.2.1 2.7 [0.2] B.2.3 5.8 2.1 
B.1.1 3.3 [0.2] B.4 5.4 1.6 
B.1.2 2.7 [0.2] B.4 6 2.2 
B.4 1.6 [0.2] B.1.1 5.4 3.4 
B.3 3.4 [0.2] B.1.1 6.4 1.8 
A.1 1.2 [0.2] A.4 12.2 10.1 
A.2 2.6 [0.3] A.4 12.1 4.6 
A.3 4.5 [0.3] A.4 7.4 1.6 
A.4 3.4 [0.3] A.5.4 7.6 2.2 
A.5.1 3.8 [0.3] A.5.4 7.1 1.8 
A.5.2 4 [0.4] A.5.4 7.6 1.9 
A.5.3 3.8 [0.2] A.5.4 5.4 1.4 
A.5.4 3.4 [0.2] A.5.3 5.4 1.5 
A.5.5 4.5 [0.3] A.5.4 8.5 1.8 
D. 0.8 [0.2] A.4 9.5 11.8 
E. 2.8 [0.2] A.4 8.4 3 
 
Table 2. Estimates of average pairwise distance and C-value within each identified H9N2 
clade. The average pairwise distance was calculated using 2842 HA nucleotide sequences (≥ 
1500 bp). Values between brackets are standard errors, obtained by a bootstrap procedure (500 
replicates). The C-value is the ratio of distance between clade and its closest clade to the 
distance within clade. 
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Criteria used for a class and clade designation 
1 The nomenclature was established based on a non redudant dataset of 2842 HA 
sequences from H9 viruses with sequence lenght ≥ 1500 bp. 
2 Classes were assigned based on phylogenetic topology distribution and confirmed by 
three different methods: Maximum Likelihood, NJ, Byesian. 
3 Clades were assigned based on both phylogenetic topology distribution and 
evolutionary distances between different taxonomic branches. Clades separation was 
confirmed using the three aforementioned methods (see point 2). 
4 New classes and clades were designated only when at least three independent isolates 
without a direct epidemiologic link (i.e. distinct outbreaks) were available. 
5 Bootstrap values at the classes and clades defining node should be ≥60%.  
6 Distinct clades should have ≥5% average distances between other clades. Distinct 
clades should have <5% average distances within the clade. 
7 Cut-off value 5% with C value ≥ 1 was fixed to assign new clades in each class. 
 
Table 3. H9N2 AI viruses, class and clade identification criteria. Text in the table cells is 
self-explaining. 
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Table S1. H9N2 virus strains representative for each clade of the identified classes. Class and clade descriptions with isolation period, 
source, and geographic location are reported. (*) B ancestral strain for B class. 
Class Clade 
Circulation 
data 
Representative strain for each clade 
Date
s 
Countri
es 
Host
s 
Full 
name 
Short name GISAID/NCBI 
 
 
 
 
 
 
 
 
 
 
 
 
A. 
A.1 1966-2000 USA, China Avian A/turkey/CA/189/66 A.1_AtkCA66 
EPI_ISL_1280/AF156390/ 
AAD49000 
A.2 1995-1996 USA Avian A/turkey/Minnesota/38391-6/95 A.2_AtkMi95 
EPI_ISL_1277/AF156387/ 
AAD48997 
A.3 1980-2012 
China, Korea, USA, 
Canada 
Avian A/goose/MN/5733-1/1980 A.3_AgoMN80 
EPI_ISL_8950/CY006042/ 
ABB88390 
A.4 1979-1984 
Hong Kong, New 
Zealand 
Avian A/duck/NZL/76/1984 A.4_AdkNZL84 
EPI_ISL_8942/CY005746/ 
ABB20444 
A.5.1 2003-2015 Singapore, USA, Georgia, 
UK 
Avian A/shorebird/Delaware Bay/283/2003 A.5.1_AshDB03 
EPI_ISL_99336/CY102744 
/AET77176 
A.5.2 2009-2010 Vietnam Avian A/duck/Vietnam/OIE-2334/2010 A.5.2_AdkVN10 
EPI_ISL_76652/ 
AB569975/BAJ10561 
76 
 
 
 
 
 
A.5.3 
 
 
 
1999-2014 
Japan, Russia, Australia, 
Chinam, Vietnam, UK, 
Netherlands, Italy, France, 
Finland, Austria, 
Switzerland, Norway, 
Portugal, South Africa, 
Zambia, Iran 
 
 
 
Avian 
 
 
 
A/duck/Hokkaido/13/00 
 
 
 
A.5.3_AdkHo03 
 
 
EPI_ISL_247/AY330340/A 
AQ97383 
 
A.5.4 
 
1993-2008 
Ireland, UK, Italy, 
Netherlands, Germany, 
USA 
 
Avian 
 
A/mallard/Ireland/PV46B/1993 
 
A.5.4_AmaIRE93 
EPI_ISL_647/AB303077/B 
AF62259 
A.5.5 1996-2009 Korea Avian, Swine A/chicken/Korea/AI-96004/1996 A.5.5_AckKo96 
EPI_ISL_68688/GU053194 
/ACZ48629 
 
 
 
 
 
 
 
 
D 
 
D 
 
1997-2001 
 
Malaysia 
 
Avian 
 
A/duck/Malaysia/2001 
 
D_AdkMa98 
EPI_ISL_96739/ 
CY073800/AEY75590 
 
E 
 
 
E 
 
2006-2013 
 
USA 
Avian, 
environment 
 
A/environment/California/NWRC186451-18/2007 
 
E_AshDB00 
EPI_ISL_132197/ 
CY122538/AET77024 
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B. 
B (*) 1999 Pakistan Avian A/chicken/Pakistan/2/1999 B_AckPa99 
EPI_ISL_146703/ 
KF188299/AGO1796
6 
B.1.1 1998-2007 
Saudi Arabia, Japan, 
Iran 
Avian A/parakeet/Narita/92A/98 B.1.1_APaNa98 EPI_ISL_128/ AB049160/ 
 
B.1.2 
 
1998-2007 
Lebanon, Iraq, Jordan, 
UAE, Israel, Saudi 
Arabia 
 
Avian 
 
A/chicken/Middle East/ED-1/1999 
 
B.1.2_AckME99 
EPI_ISL_68504/GU053201 
/ 
B.2.1 1998-2009 Iran, Iraq Avian A/chicken/Iran/B102/2005 B.2.1_AckIR05 
EPI_ISL_11184/ 
EF063733/ABO09919 
B.2.2 2003-2013 
India, Bangladesh, 
Kuwait 
Avian A/chicken/Chandigarh/2048/2003 B.2.2_AckCh03 
EPI_ISL_78703/CY068643 
/ADL64047 
B.2.3 2008-2015 
Afghanistan, Pakistan, 
Iran 
Avian 
A/chicken/Afghanistan/329-6vir09-AFG- 
Khost9/2008 
B.2.3_AckAf08 EPI_ISL_63785 
B.2.4 2009-2011 Nepal, India Avian A/chicken/Nepal/2490/2009 B.2.4_AckNE09 
EPI_ISL_124228/ 
JX273549/AFO83282 
B.2.5 2005-2013 
Pakistan, Afghanistan, 
Iran 
Avian A/chicken/Pakistan/UDL-01/2005 B.2.5_AckPA05 
EPI_ISL_29787/ 
CY038410/ACP50642 
B.2.6 2005-2014 
Saudi Arabia, UAE, 
Qatar, Israel, Libyan 
Avian A/chicken/Saudi Arabia/582/2005 B.2.6_AckSA05 
EPI_ISL_124235/JX27355 
6/AFO83289 
B.2.7 2006-2015 
Israel, Egypt, Lebanon, 
Jordan 
Avian A/chicken/Israel/1525/2006 B.2.7_AckIS06 
EPI_ISL_64314/FJ464728/ 
ACJ68774 
B.3 1999-2015 
Hong Kong, USA, 
Vietnam 
Avian, Human A/Quail/Hong Kong/G1/97 B.3_AquHKG19
7 
EPI_ISL_1268/ AF156378/ 
AAF00706 
B.4 2000-2002 UAE Avian A/quail/Dubai/303/2000 B.4_AquDu0
0 
EPI_ISL_11171/ 
EF063512/ABM21877 
 
 
 
 
 
C. 
C.1 2000-2005 Hong Kong, China Avian/Human A/quail/Shantou/1318/2000 C.1_AquSh00 
EPI_ISL_11272/ 
EF154910/ABM46230 
 
C.2 
 
1994-2014 China, Hong Kong, 
Japan 
Avian, Swine, 
Human, 
Environment 
 
A/chicken/Beijing/1/1994 
 
C.2_AckBe94 EPI_ISL_146731/ 
KF188294/AGO17871 
C.2.1 2003-2013 
China, Hong Kong, 
Japan 
Avian A/guinea fowl/Hong Kong/NT101/2003 C.2.1_AgfHK03 
EPI_ISL_146694/ 
KF188382/ABB58955 
C.2.2 2001-2015 
Hong Kong, Vietnam, 
China 
Avian, 
Environment 
A/chicken/Shandong/wd01/2007 C.2.2_AckSd07 
EPI_ISL_24922/ 
FJ231868/ACI2260
8 
C.2.3 2007-2009 China Avian A/chicken/Hebei/A/2007 C.2.3_AckHe07 
EPI_ISL_76661/ 
GQ202056/ACR5617
8 
1
7
6
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Phylogeographic analysis for AI H9N2 HA 
In order to determine the worldwide dissemination of AI H9N2, the sequences of the HA 
gene were grouped into eight geographic areas, namely: (i) North America, (ii) Europe, (iii) 
Oceania, (iv) China, (v) Meddle East, (vi) South, (vii) South east and (viii) East Asia. The 
final dataset included 357 viruses that could be used for in-depth special analysis. Through 
Posterior distribution under the Bayesian framework, we reconstructed genealogical trees 
with time-scale and inferred ancestral locations of each branch using sequences’ sampling 
collection dates and locations. The time-scaled phylogeographic maximum clade credibility 
(MCC) tree of HAs implemented in BEAST (see methods) and the root state posterior 
probability are illustrated in Figure 2 (phylogeography tree) and Figure 3 (phylogeography 
map), in which the most probable location of each branch is assigned different colours and the 
calibrating time-scale. Numbers at branch points in Figure 2 are reported where state 
probabilities with values ≥ 0.55 correspond to the most relevant events (i.e. to area-area 
transitions rather than to intra-areal ones). Such transition events supported by Bayes factor 
>3 are graphically depicted as arrows (with class-coded colors) in Figure 3 map. For graphical 
reasons (saving space to fit the one page format), names of the 357 individual viral strains are 
not reported in Figure 2; however, the same tree with all virus names is presented in 
Supplementary figure S2. 
Our phylogeographic results suggest that the North American strains are ancestral for all 
H9 subtypes. Those ones introduced in China then were spreading worldwide. In particular, 
most probably American Class A strains reached China first and Chinese clades moved in turn 
to Europe, southeast and East Asia and Australia by migratory birds. Similarly, Class B 
(mostly present in poultry), spread from China to the Middle East, and from the Middle East 
to south Asia. Class C can also be referred to as China class because it evolved and expanded 
79 
 
 
mostly in China; however, different viruses of class C were introduced and circulated in east 
and south Asia. Class D formed a separate class in southeast Asia, while class E evolved by 
back migration events of Chinese viruses to North America. The overall spatiotemporal 
representation of phylogeographic evolution and worldwide spreading of the H9 subtypes is 
presented in Supplementary visual animation S1. 
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Figure 2. Maximum clade credibility (MCC) phylogenies inferred for the HA gene 
sequences of 357 viruses of AI H9 subtype. Branches are coloured according to the most 
probable ancestor location (in terms of geographic area) of their descendent nodes. Timeline 
at the bottom indicates the years before the most recent sampling time. Numbers are reported 
at branch points where state probabilities with values ≥0.55 correspond to geographic area 
transition events. 
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Figure S2. Maximum clade credibility (MCC) phylogenies inferred for the HA gene 
sequences of 357 viruses of AI H9 subtype. Branches are coloured according to the most 
probable ancestor location (in terms of geographic area) of their descendent nodes. Timeline 
at the bottom indicates the years before the most recent sampling time. Virus name 
information is reported in details. 
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Figure 3. Phylogeography worldwide mapping and spreading of AI H9 subtype viruses. The eight geographic areas in which H9 viruses are 
so far known to circulate are differently coloured. Viral transition from a geographic area to another one with the well supported Bayes factor > 3 
and state probabilities values ≥0.55 are represented by arrows with colour code based on corresponding H9 classes. 
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Clustering by electrostatic features for AI H9N2: heat maps and epograms 
A recent bioinformatic work has shown that the integration of sequence and structural 
analyses for HA (and especially its RBD) can shed more light on the evolution and spreading 
of AI H5N1 viruses by unveiling surface patches as possible evolutionary fingerprints 
(Righetto et al., 2014). Therefore, when considering findings emerged from comparative HA1 
and RBD analysis, we decided to check whether variation in electrostatic features of H9N2 
would relate to phylogenetic data, as observed for H5N1 (Righetto et al., 2014). 
Representative strains for each clade of the five H9N2 classes identified in our 
phylogenetic analysis are summarized in Supplementary table S1. In order to quantitatively 
evaluate the electrostatic distance, clustering of the spatial distributions of the electrostatic 
potentials was obtained by WebPIPSA (Protein Interaction Property Similarity Analysis) 
(Richter et al., 2008). Figure 4 depicts the heat map and density plot for the RBD subregion 
of HAs from such representative strains. High electrostatic distance (dark blue, violet or 
magenta colors, see density plots) clearly separates classes A, D and E (typical of wild birds) 
from B and C (common to poultry birds), whereas the electrostatic distance between B and C 
is lower, as highlighted by prevalence of the light blue color. Therefore, clustering of H9N2 
classes by electrostatic features shows substantial agreement to phylogenetic grouping, apart 
from a few exceptions: for instance, in terms of electrostatic distance, B3 and B4 are closer to 
C2 (light blue) than to B2 strains. It can be noticed that B3 and B4 clades used for this 
analysis were both isolated from the same host bird (quail). In addition to heat maps and 
corresponding density plots, the distance matrices of the electrostatic potentials were also 
displayed as trees referred to as ‘epograms’ (electrostatic potential diagrams). The epogram 
for RBD confirms grouping of the A wild bird cluster as well as homogeneity of class C and 
B2 clades; moreover, once again B3 sorts with C clades rather than with B ones (Figure 5). 
  
84 
Both heat map and epogram for HA1 subregion (not shown) confirmed clustering from the 
RBD analysis. 
 
Figure 4. Heat map and density plot for the RBD subregion from representative H9N2 
strains. The electrostatic distance formula is reported. In both density plot and heat map, 
warm to cold color shift corresponds to increasing electrostatic distance.  
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Figure 5. Electrostatic potential diagram (epogram) for the RBD subregion from 
representative H9N2 strains. The electrostatic distance formula is reported. The two main 
clusters are 3/4 bordered by red lines.  
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Variation in charge distribution among AI H9N2 classes and strains 
In depth analysis of the distribution of charged residues, of their variation in number and 
position and of isocontours from the different HA subregions, further confirmed that variation 
especially concerns the RBD subregion and suggested possible electrostatic fingerprints are 
associated to different H9N2 classes. 
Class-associated 'charge redistribution' is found to occur at RBD positions 135, 146 and 
162: the net charge for these three positions is zero in all classes (as the sum of two opposite 
charges and a non charged residue), but the charge distribution pattern shared by the 'wild 
bird' classes A, D and E is different from the pattern conserved in viruses from the 'poultry' 
classes B. and C. In fact, distribution at 135-146-162 is neutral-positive-negative in A-D-E, 
and negative-neutral-positive in B-C (Table 4). In particular, at position 135, almost all 
viruses from class A share a non charged residue (167/177 strains) with prevalence (127/177) 
of Asn, which is 100% conserved (16/16) in classes D-E; mutation to charged residue 
(N135D) only concerns 10/177 viruses from clades A.5.3, A.5.4 and A.5.5. Instead, 
negativization at position 135 is most often observed in both classes B (311/364) and C 
(1011/1102), with prevalence of Asp/Glu over other amino acids in almost all B-C clades. A 
compensatory mechanism is observed for exceptions, i.e. for those clades that do not share a 
negative charge at position 135. For example, clade C.1 lacks the negative charge of classes 
B-C and shares instead (31/31 sampled viruses) N135 with classes A-D-E; however, this is 
compensated as C.1 is also the only B-C clade missing a positive charge at position 131. 
Similarly, B3 (showing prevalence of Gl35) is also the only B-C clade with a negative charge 
(Glu) instead of a non charged residue at position 180. Therefore, compensatory mutations in 
the RBD seem to keep class-specific fingerprints and net charge, while progressively 'sliding' 
positions of charged residues over RBD sites in the viral population. Residue 146 is His in 
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169/177 viruses from class A and in all D-E strains, while prevalence of Gln is observed in all 
clades from class B (363/364) and C (1075/1102). The only exception in class A is clade 
A.5.2, showing Q146 (like B-C) instead of H146 (common to A-D-E). However like for 
example above a counterbalancing unique mutation is observed: depositivization at position 
146 of A.5.2 is compensated by peculiar denegativization at position 162 (E162N). In most 
(114/177) class A viruses and in all D-E strains, residue 162 is Glu except for clade A.5.5, 
showing mutation E162W in 51/51 viruses. Intriguingly, the lost negative charge is rescued at 
the contiguous N-terminal position 161 by the equally conserved (51/51) and peculiar 
mutation N161D, suggesting the negative charge at position 162 (or 161) as a landmark for 
A-D-E viruses. Instead, in viral strains from classes B-C the major residues are Arg and Gln, 
with prevalence of the former over the latter in all clades but B.2.4 and C.2.2, where reverse 
prevalence is observed. Therefore, ongoing positivization of position 162 seems to be a 
landmark as well for viruses circulating in poultry. Altogether, counterbalancing mutation 
pairs observed at positions 131-135, 135-180, 146-162 and 161-162 seem to support the 
compensatory mechanism suggested above for mantaining the overall net charge of the RBD 
while sliding charges over the RBD itself, i.e. for keeping class specific landmarks along with 
contemporary creation of novel fingerprints. 
A second and different kind of variation in electrostatic features is observed at positions 
180 and 186 of the RBD (Table 4). In all H9N2 classes, the net charge for this amino acid pair 
is zero. However, in A-D-E viruses this results from the sum of opposite charges (+1 -1 = 0), 
while in B-C viruses, it depends on replacement of both charged residues by neutral ones (0 + 
0 = 0). Therefore in this case differently from previous examples of charge redistribution 
manteinance of the net charge is associated to a decrease in the percentage of charged 
residues in the RBD.  
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HA 
subtype 
numberin
g 
HA (mature chain) position number 
H9N
x 
131 135 146 161 162 165 18
0 
186 198 216 217 
H7N
x 
127 134 145 162 163 166 18
1 
187 199 217 218 
H5N
x 
133 141 152 167 168 171 18
6 
192 204 222 223 
H3N
x 
137 145 156 171 172 175 19
0 
196 208 226 227 
H1N
x 
134 142 153 168 169 172 18
7 
193 205 223 224 
Clad
e 
Strain
s 
Fully / most conserved amino acid for each 
clade A.1 4 R N H N E N E K D Q Q 
A.2 3 K N H T E N E K D Q Q 
A.3 33 K N H N E N E K D Q Q 
A.4 8 K N H N E N E K D Q Q 
A.5.1 15 A N H N E N E K D Q Q 
A.5.2 3 A N Q N N S E K D Q Q 
A.5.3 48 K N H N E N E K D Q Q 
A.5.4 12 R N H N E N E E D Q Q 
A.5.5 51 K G H D W N E K D Q Q 
D 3 K N H N E S E K D Q Q 
E 13 K N H N E S E K D Q Q 
B 3 K D Q N R S A V D Q Q 
B.1.1 30 K D Q N R S A I D L Q 
B.1.2 44 K D Q N R S A I D L Q 
B.3 7 R G Q N R S E I D L Q 
B.4 7 K D Q N R S A T D L Q 
B.2.1 33 K D Q N R D A T N L I 
B.2.2 36 K D Q N R D A T N L I 
B.2.3 9 K N Q N R D A T N L I 
B.2.4 7 K D Q N Q D A T N L I 
B.2.5 31 K D Q N R D A T N L I 
B.2.6 33 K E Q N R D T T N L I 
B.2.7 124 K D Q N R D A T N L I 
C.1 31 N N Q N R S V T D L T 
C.2 224 K D Q N R N T T D Q Q 
C.2.1 150 K D Q N R N A T D L Q 
C.2.2 694 K D Q N Q N T T D L Q 
C.2.3 3 K D Q N R N V T D L Q 
 
Table 4. Class and sub-class specific variation at the RBD in H9N2 viruses. The number 
of strain sequences and the most represented residue for each amino acid position (columns) 
are reported for each clade (rows). Negatively charged, positively charged and hydrophobic 
residues are highlighted by red, blue or yellow background, respectively. Position numbering 
for four HA subtypes is reported.  
  
89 
Class and sub-class specific variation in electrostatic and hydrophobicity 
features 
Table 4 also reports intriguing variation at the contiguous positions 216 and 217. Clades 
from classes A-D-E share at position 216 a highly conserved (176/177 strains) polar residue 
(Gln), while polar to hydrophobic transition is clearly apparent in classes B and C. In 
particular, the 'original' Gln is replaced in the most of strains (1256/1466) by the hydrophobic 
residue Leu, showing prevalence in all clades (from classes B-C) but 'B' (the ancestral one 
without numbering) and C.2. However, Gln is still present in 202/1466 B-C strains and the 
most represented residue in clades 'B' and C.2. In the next position (217), sub-class variation 
is observed: only B.2.x viruses share a hydrophobic residue (Ile), while Gln is common to all 
other clades in classes A-B-C-D-E. When inspecting in more detail distribution of residues 
among individual clades and strains, the picture is meaningfully different from position 216. 
In addition to classes A-D-E (176/177 strains), the 'original' Gln is highly conserved also in 
class C (900/1102 strains) and in C1 the major residue is anyway a polar one (Thr, in 30/31 
strains). Instead, a complex picture is displayed in class B: Gln is still 100% conserved in 
clades B, B1.1, B1.2 and B3, whereas polar to hydrophobic transition is ongoing in clade B4 
(4 hydrophobic strains out of 7) and fully fixed (100% of strains) in the whole B.2.x 
subgroup. Such specific variation in sub-class B.2.x is only apparently restricted to 
hydrophobic patches, as 'charge sliding' is observed between positions 165 and 198. In 
particular, all H9 clades but B2.x share a 100% negatively charged residue at position 198, 
which is replaced in B2.x by a polar amino acid (mostly, Asn). Such a peculiar (with respect 
to other H9 viruses) denegativization is however compensated in B.2.x by an equally peculiar 
acquisition of a negative charge at position 165, where Asp is 100% conserved.  
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Residues involved in changes at the H9N2 RBD are surface exposed 
The RBD from the solved structure of the H9 HA was viewed to highlight the nine amino 
acid positions involved in class or sub-class specific variation: as shown in Figure 6, all such 
positions are exposed at the RBD surface. The RBD subregions (130-loop, 190-helix and 220-
loop) mediating SA binding are highlighted in yellow. The three residues 135, 146 and 162 
involved in class specific 'charge redistribution' are highlighted in orange; in particular, 146 is 
close to 190-helix, 135 is part of 130-loop and 162 is surface exposed as well. Position pair 
180-186 (mediating 'charge loss' in the A-D-E to B-C transition) is highlighted in purple and 
is part of 190-helix. Concerning the four positions involved in class and sub-class variation 
(highlighted in green), positions 216 and 217 are part of 220-loop, while 165 and 198 
protrude at the other 'side'. Finally, positions 131 and 161 involved in compensatory variation 
(see Table 4) were also confirmed to be surface exposed (not shown). 
Given that surface location is confirmed for all aforementioned positions, variation in 
H9N2 among different classes, subclasses and clades can be viewed and analyzed in more 
depth by comparison of the electrostatic isocontours, which were determined as previously 
reported (Righetto et al., 2014; see also the methods section). Prior to starting electrostatic 
analysis, we checked the quality of models because shaping of the isopotential contour can be 
influenced by the orientation of side chains. However, model refinement proved to be 
unnecessary because of the very high average sequence identity (around 90%) of the H9N2 
target sequences to the H9 template, as previously observed with H5N1 models (Righetto et 
al., 2014). 
Figure 7 shows the isopotential contours from two viral strain that are well representative 
for electrostatic fingerprints from 'wild bird' viruses (classes A-D-E) and 'poultry' viruses 
(classes B-C). In fact, both strain A.1_AtkCA66 and C.2.3_AckHe07 match in all positions 
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patterns in Table 4 typical for classes A-D-E or classes B-C, respectively. At position 162, the 
two strains clearly show the opposite charges; concerning position 135, the expected contours 
are found again, as A.1_AtkCA66 shows no charge while in C.2.3_AckHe07 a negative 
protrusion is found in the corresponding area. However, not always expectations are respected 
and comparison of the 180-186 amino acid pair clearly shows that the loss of both charged 
residue in the A-D-E to B-C transition does not just result in 'neutralization' of the 
corresponding surface area. In fact, in spite of the expected red(Glu)-to-neutral(Val) shift, 
position 180 shows in C.2.3_AckHe07 a seeming positivization (increased blue area), 
possibly because of the enlargement of electrostatic clouds from neighboring occurs. 
For completeness of information, the isopotential contours of the RBDs from all 
representative strains used for creating the heat map and epogram in figures 4 and 5 are 
presented in Supplementary Figure S3. 
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Figure 6. Location at the RBD surface of residues involved in class and sub-class specific 
variation in H9N2. Both 0° view (left image) and 180° view (right image) are shown. The 
three regions (130-loop, 190- helix and 220-loop) that mediate binding to the sialic acid (SA) 
moieties from the host cell (Wilson et al., 1981; Kobayashi et al., 2012) are highlighted in 
yellow. Color coding for amino acid positions is the following: 135, 146 and 162: orange; 180 
and 186: purple; 165, 198, 216 and 217: green. 
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Figure 7: Comparison of representative profiles for the isopotential RBD contour in 
H9N2. Four 90° stepwise rotation view are presented for each representative RBD 
electrostatic isocontour. Names of the specific H9N2 virus strains are reported. Arrows for 
specific residues are color-coded according to Figure 6. 
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Figure S3. Isopotential contours of the RBD from representative H9N2 virus strains. 
Four 90° stepwise rotation views are presented for each representative RBD electrostatic 
isocontour. Names of the H9N2 virus strains are reported and they are the same as in figures 4 
and 5.  
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Discussion and conclusions 
Haemagglutinin has the role of main viral surface antigen in the stimulation of the 
neutralizing antibody response (Velkov et al., 2013) and so far, classification of viral HA has 
been based upon antigenic and phylogenetic analyses (Stanekova and Vareckova, 2010). 
However, comparative structural analysis of HA can provide functional insights on surface 
regions possibly crucial to antigenicity and binding to the host cells. In fact, recent work on 
H5N1 demonstrated that electrostatic and hydrophobicity variation at the RBD surface relates 
to both evolution and spreading of viral clades and is able to provide fingerprints and infer 
trends to complement phylogeny and functional analyses (Righetto et al., 2014). Intriguingly, 
when comparing RBD regions, H5 is structurally quite closer to H9 than H3 and H7, and 
when RBD electrostatic potential is considered, H5 is even closer to H9 (member of a 
different phylogenetic HA group) than to H2 (member with H5 of the same phylogenetic 
group) (Righetto et al., 2014). Therefore, the possibility that similar mechanisms might 
underlie H5 and H9 evolution and spreading further prompted us to investigate on H9 
evolution and on surface features of the H9 HA. 
We developed a method for the HA clade nomenclature of all AI H9N2 subtypes, based 
on the evolutionary dynamics of a large and non redudant viral strain dataset. Clade 
assignments were made by following several criteria (Table 3), collectively used to rationally 
name groups by clade numbering. Based on phylogenetic topology, five different genetic 
classes could be distinguished, which so far consist of twenty-seven clades according to the 
different molecular analyses and fixed criteria. Once further clades arise along evolution of 
H9N2 viruses, such a nomenclature is ready to be expanded (by enlarged numbering) based 
on already fixed criteria. Circulation and evolution of the H9N2 HA gene show a remarkable 
similarity to the H5 subtype and notable difference from the typical evolution of H3. The 
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evolution of the human influenza viruses since 1968 is characterized by a limited diversity 
among circulating strains. This lack of diversity is likely the consequence of rapid extinction 
after the emergence of new clades and lineages. As expected, the evolutionary tree of human 
influenza HA genes has extended trunks and extremely short branches; conversely, AI H9N2 
strains show extended branches as these viruses continue to co-circulate in different regions 
and host species and this allows the clades for further evolving and differentiating. Therefore, 
a standard nomenclature system for H9N2 classification is needed now in order (i) to provide 
a rationale for the AI H9N2 evolution, and (ii) to properly relate investigations worldwide 
thanks to robust guidelines. Moreover, we believe that the rapid and accurate annotation of 
clades will aid molecular epidemiologic assessment and support public health interventions. 
Last but not least, shared nomenclature criteria can boost correlation analyses and favour 
proper naming of newly identified strains along epidemiological analyses. 
As a fundamental component of modern biogeography (Riddle, 2009) and an approach of 
great impact on the most basic of biological questions, phylogeography is actually a hot 
research field boosting studies aimed at clarifying evolutionary dynamics in most life sciences 
disciplines (Turchetto-Zolet et al., 2013; Brown et al., 2014; Ni et al., 2014; Gräf et al., 2015; 
Pyron, 2015; Zhang et al., 2015; Maixner et al., 2016; Stacy et al., 2016) including analysis 
of influenza viruses (Lu et al., 2014; Bedford et al., 2015; Hill et al., 2015; Pollett et al., 
2015; Tian et al., 2015). In addition to the classification scheme and as a complement to it, 
phylogeographic data can provide further information on the spatiotemporal evolution, 
correlation and spreading of AI H9N2 viruses from the beginning to current trends. 
Relationship among variation in electrostatic features, viral evolution and clades spreading 
observed for H9N2 in this work confirms and further strengthen previous observations on 
H5N1 AI viruses, in which the evolution of circulating clades is accompanied by 'charge 
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redistribution' at the RBD (Righetto et al., 2014). Moreover, most of changes occuring at the 
RBD in H9N2 viruses seems to concern sites known to play a special role in RBD 
interactions, immune escape and host specificity. In particular, three RBD subregions mediate 
binding to the sialic acid (SA) moieties from the host cell and they are major antigenic 
determinants hence involved in immune escape/antigenic drift:130-loop (H3 residues 135-
138), -helix (H3 residues 190-198) and 220-loop (H3 residues 221-228) (Wilson et al., 
1981; Kobayashi et al., 2012). For Readers' convenience, in addition to H9 and H3 numbering 
systems, Table 4 also shows HA mature chain numberings for subtypes H1, H5, and H7, all 
five numberings being based on the most recently published table of correspondence (Burke 
and Smith, 2014). 
As described in the results section, changes at positions 162 and 217 of H9N2 HA result 
in either class or sub-class specific variation of charge or hydrophobicity features of the RBD. 
In particular, position 162 is involved together with positions 135 and 146 in class specific 
'charge redistribution' and, when denegativization occurs at position 162 in two clades from 
class A, this is compensated by either depositivization of residue 146 (in A5.2) or 
negativization of residue 161 (in A5.5). Sub-class specific, polar to hydrophobic transition 
occurs instead at residue 217. The involvement in immune escape of mutations at both 
positions 162 and 217 in H9N2 has been recently reported (Peacock et al., 2016). Indeed, as 
part of the 220-loop, position 217 is also likely involved in increased virus binding to α2-6 
SA and thus in improved affinity to the human host; for instance, residue 224 in H1N1 (217 
in H9) mediates hydrogen bond interactions with α2,6-SA (Chutinimitkul et al., 2010). 
Evidence on the involvement of this RBD position in the modulation of host range is also 
based on previous studies on H5N1 (Gambaryan et al., 2005). Position 227 (H3 numbering) is 
located between amino acids 226 and 228, both being part of the 220-loop and playing a key 
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role in receptor specificity and host range restriction of influenza A viruses (Vines et al., 
1998). In this work, class-specific variation in H9N2 position 216 (226 in H3) is observed 
(Table 4). Positions 180-186 in H9N2 (where the conserved dual opposite charges pair in 
classes A-D-E shifts to a non-charged pair in classes B-C, see previous sections) both belong 
to the 190-helix of the RBD involved in binding to SA moieties from the host cell (Wilson et 
al., 1981; Kobayashi et al., 2012). Contemporary loss of the two opposite charges is somehow 
'compensatory' in that saving the original net charge of the RBD. It is noteworthy that in 
influenza A viruses, amino acid substitutions increasing (charge+) and decreasing (charge-) 
the charge of the SA binding RBD region can modulate binding avidity and affinity, and thus 
contemporary charge+ and charge compensatory substitutions are often observed and likely to 
compensate gain and loss effects and to ensure the HA-NA charge balance is kept (Kobayashi 
et al., 2012). However, in A-D-E to B-C class transition, compensation only keeps the net 
charge, while the overall loss of two charged residues from the RBD in B-C class viruses 
occurs. This in turn is likely to favour immune escape, because of both the location of the two 
residues and the well-known role of charged amino acids in modulating protein antigenicity 
and immunogenicity. In fact, it is well known and an established evidence that both positively 
and negatively charged residues improve the antigenic recognition (up to several folds, 
depending on their number in the antigenic site) by creating further salt bridges with the 
recognizing antibody complementary surface (Young CR, 1984; Farber et al., 2007). 
As shown in Table 4, charge variation also occurs at position 146 (involved with 135 and 
162 in 'charge redistribution' on the RBD, see results), which is exposed at the RBD surface 
close to 190-helix (Figure 6). Based on the aforementioned role of 190-helix in binding SA 
moieties from host cells, changes like the observed depositivization at position 146 are likely 
to influence binding affinity and specificity. Considering that chickens possess both α-2′3′ and 
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α-2′6′ SA receptors (Gambaryan et al., 2002), it is tempting to speculate that such changes 
could be linked to host adaptation and species specificity (Perez et al., 2003). 
In addition to represent a valuable complement to integrate phylogenetic and antigenic 
studies, structural analyses are also of great help to improve sequence-based, functional 
comparison. Sequence comparison was able to infer class and sub-class specific fingerprints 
presented in Table 4 as sequence patterns; however, only once sequence analysis was 
complemented by the structural approach, a real-estate picture of the system emerged. 
Comparison of the electrostatic isocontours showed that identified mutations cannot be 
considered as just isolated 'point changes'. In fact, surface features that are pivotal players in 
regulating molecular interactions e.g. immune escape and host specificity are modulated by 
the direct change of any mutated residue, as well as by the effects that such a mutation may 
exert on the local equilibrium in the surrounding area (salt bridges or repulsions, 
hydrophobicity changes, decreased or increased charge density etc.), as shown by the 
unexpected variations observed in charge clouds. 
In conclusion, although much further work is needed to clarify in details the complex 
network of equilibria that can be altered by specific mutations, evidence from this study 
supports the integration of up-to-date phylogenetic and phylogeographic analyses with 
sequence-based and structural investigation of surface features as a front-end strategy for 
inferring trends and relevant mechanisms in influenza virus evolution. 
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Abstract 
Since the ‘90s, avian influenza viruses (AIVs) of the H9N2 subtype have been causing 
infections in the poultry population around the globe. In Iran, H9N2 has been identified for 
the first time in 1998 and it is still circulating in the country, with a mortality rate ranging 
between 20% and 60% in the affected farms. Irrespective of the national control measures 
implemented, including mass vaccination of poultry, the virus has rapidly spread and 
currently it can be considered endemic. In this study, phylogenetic and phylogeographic 
analyses were carried out to obtain a comprehensive picture of the evolution dynamics of the 
Iranian H9N2 AIVs and to evaluate the possible effect of vaccination on the evolution and 
population dynamics. Analyses revealed that since 1998 four important introductions of 
H9N2 occurred in Iran and phylogeography indicated that the introductions had different 
origin. Amino acid analyses of the HA gene showed the presence of a positive selection 
pressure in the Iranian H9N2 viruses isolated after the implementation of the vaccination 
program in poultry. Additionally, analyses revealed that the first Iranian introduction was 
characterized by the presence of the amino acids Q and L at the position 226 with the same 
percentage, while the new introductions comprised mainly the amino acid L at this position. 
Data generated in this study provide complete and novel insights into the evolution and 
phylogeography of the Iranian H9N2 AIVs and highlight different important epidemiological 
aspects which may help the Iranian veterinary community to eradicate ongoing and future 
H9N2 outbreaks. 
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Background 
Avian influenza viruses (AIVs) of the H9N2 subtype are widespread worldwide, being 
endemic in poultry populations in Asia and the Middle East (Capua and Alexander, 2007). A 
significant proportion of recent H9N2 AIV isolates contains the L226Q (H3 numbering) 
amino acid substitution in the hemagglutinins (HAs) which show preferential binding to 
analogues of receptors with sialic acid linked to galactose by α2,6 linkage (SAα2,6Gal), a 
phenotypic portrait characteristic of human influenza viruses. Thus, these AIVs seem to 
possess one of the key elements for infection in humans (Lin et al., 2000). Since 1998, H9N2 
AIV outbreaks have been one of the major problems of the Iranian poultry industry (Nili and 
Assasi, 2003). These viruses have spread in poultry flocks throughout the country; therefore, 
a vaccination strategy using an inactivated H9N2 vaccine was adopted. Despite the 
vaccination program, outbreaks have continued to occur in several broiler flocks, with great 
economic losses from either mortality and weight loss (Bahari et al., 2015). The prolonged 
circulation of influenza viruses in a partially immunized population may have a direct impact 
on the evolution of the virus, particularly on the occurrence of antigenic drift (Shih et al., 
2007; Smith et al., 2004). Different studies and monitoring projects have reported that many 
substitutions have occurred in the HA gene of the Iranian H9N2 viruses in recent years 
(Norouzian et al., 2014), which may affect the pathogenicity and the antigenicity of the virus. 
Therefore, it is important to investigate and monitor whether the circulation of H9N2 AIVs 
have undergone further significant genetic changes, in particular under the selection pressure 
of vaccination. Phylogenetic and evolutionary dynamics analysis of Iranian H9N2 AIV strains 
can be an effective approach for vaccine development and to better understand the 
evolutionary trend and the introduction sources of these viruses in the Iranian geographic 
area, in order to prevent and eradicate the circulation of H9N2 AIVs. 
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In the present study, a deep investigation to obtain a comprehensive picture of the 
dynamics and the evolution of Iranian H9N2 viruses was performed. Furthermore, the 
phylogenetic relations grouping the various introductions and the spread to other countries 
were investigated to reveal the time and the location of the most recent ancestor, highlighting 
the nucleotide substitution rates and depicting the population dynamics and the extent of its 
molecular change since the H9N2 AIV first detection in Iran and after the application of a 
vaccination program. 
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Methods 
Virus sequences 
The HA gene nucleotide sequences of 88 Iranian H9N2 viruses and representative strains 
from G1 lineage were downloaded from publicly available databases: GenBank National 
Center for Biotechnology (NCBI) and Influenza Sequence Database of Global Initiative on 
Sharing Avian Influenza Data (GISAID). The analysis included only nearly full-length HA 
sequences (at least 1,500 nt in length) to ensure a robust analysis. 
 
Phylogenetic analysis 
Sequences were aligned using MAFFT version 7 (http://mafft.cbrc.jp/alignment/server/), 
and Maximum likelihood (ML) trees were estimated using the best-fit general time-reversible 
(GTR) model of nucleotide substitution with gamma-distributed rate variation among sites, 
and a heuristic SPR branch-swapping search available in PhyML version 3.0 (Guindon and 
Gascuel, 2003). Bootstrap analysis with 100 replicates was also employed. To confirm 
different genetic groups and introductions, genetic distances among Iranian H9N2 viruses by 
using MEGA5 software (Tamura et al., 2002) were calculated. The distances were inferred by 
pair-wise analysis and the number of base substitutions per site was calculated by (p-distance) 
model. Rate of nucleotide substitutions per site, year and time to the Most Recent Common 
Ancestor (tMRCA) for datasets, comprising the HA gene of Iranian viruses, were estimated 
using the BEAST program, version 1.8 (Drummond et al., 2007), which employs a Bayesian 
Markov chain Monte Carlo (MCMC) approach. 
The dataset was analysed with the codon-based SRD06 nucleotide substitution model and 
the Skyline coalescent prior. Two molecular clock models, a strict (constant) and an 
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uncorrelated lognormal relaxed clock were compared by estimating the marginal likelihood 
implemented in the Tracer program (Rambaut A et al., 2014) Prior to BEAST analysis, an 
independent estimate of nucleotide substitution rate was obtained using a root-to tip 
regression method available in the Path-O-Gen program (kindly provided by Andrew 
Rambaut, University of Edinburgh; http://tree.bio.ed.ac.uk/software/pathogen/), in which 
genetic distances and molecular-clock assumption were estimated from a maximum 
likelihood (ML) tree plotted against sampling date. 
 
Phylogeography analysis 
The HA gene sequence alignment including 160 H9N2 viruses from Iran and the most 
related clades was used for phylogeography analysis. To obtain the tree with robots, the Path-
O-Gen tool was used for investigating the temporal signal and the clocklikeness of molecular 
phylogenies, and viruses without molecular-clock were removed from the alignment B.2 
ancestor strains. Time-scaled phylogenies of the Iranian H9N2 HA gene were inferred by 
Bayesian Markov Chain Monte Carlo (MCMC) using BEAST v1.8.0 (Drummond et al., 
2007) using the SRD06 codon position model and the uncorrelated log-normal relaxed clock 
model under a Bayesian skyline coalescent tree prior to the MCMC simulations (Jin et al., 
2014). For the dataset, 500 million generations, with sampling every 50,000 steps, were 
performed. Convergence and effective sampling size (ESS) of estimates were assessed by 
visual inspection using Tracer v1.6 (Rambaut et al., 2014). The Maximum Clade Credibility 
(MCC) trees with temporal and spatial annotation were summarised with a 10% burn-in 
removed, using TreeAnnotator v1.8.0 in the BEAST package and the topologies of the MCC 
trees were visualized using FigTree v1.3.1(http://tree.bio.ed.ac.uk/software/figtree/). 
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To animate viral dispersal over time, annotated MCC trees were converted into a keyhole 
markup language (KML) file using SPREAD v1.0.6, which can be visualised by Google 
Earth website platform (http://earth.google.com) (Bielejec et al., 2011). A Bayes Factor (BF) 
comparison test (Suchard et al., 2001) was used to identify significant non-zero migration 
rates using SPREAD v1.0.6. 
 
Analysis of selection pressure 
Gene and site-specific selection pressures for the HA protein of the Iranian H9N2 viruses 
were measured as the ratio of non-synonymous (dN) to synonymous (dS) nucleotide 
substitutions per site. In all cases, dN/dS ratios were estimated using the single-likelihood 
ancestor counting (SLAC) and fixed-effects likelihood (FEL). The codon-based maximum 
likelihood (IFEL) and FUBAR (Kosakovsky Pond et al., 2005) methods were available at the 
DataMonkey online version of the HY-Phy package (http://www. datamonkey.org). Using 
phylogenetic Bayesian tree along with Mesquite software, the evolution and the character 
history of amino acid 226 (H3 numbering) was reconstructed. Using a Bayesian phylogenetic 
tree and an amino acid sequence distribution, Mesquite reconstructed the amino acid character 
states at ancestral nodes. Mesquite uses either parsimony, likelihood or Bayesian methods to 
reconstruct ancestral states and has several display methods, including "Trace Character 
History" which paints the branches of the tree to show the reconstruction. 
 
Results 
The maximum-likelihood phylogenetic tree (Figure 1), inferred from the H9N2 HA gene 
alignment of 88 Iranian AIVs and representative strains, showed that Iranian strains belong to 
four distinct genetic group, herein named clade B.1.1, B.2.1, B.2.3 and B.2.5, as defined by 
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high bootstrap values (>70%). The average distance between clades is >7% and the average 
distance within the clades is <5%. At population level, most of the Iranian strains isolated 
from 1998 to 2007 cluster into clade B.1.1, showing that the first introduction of Iranian 
H9N2 AIVs since 2003 was from clade B.2.1 that circulated until 2009 creating thus the 
second introduction. Since 2009, the third introduction from clade B.2.5 can be observed, 
which clusters with viruses from Pakistan and Afghanistan. In 2014, the fourth introduction 
from clade B.2.3 can be observed, which clusters with viruses from Pakistan and Afghanistan 
(Figure 1).  
  
120 
 
Figure 1. Maximum-likelihood tree of Iranian H9N2 AI viruses from 1998 until 2014 
and Eastern countries constructed by PhyML. Colours and classification were by Heidari. 
Iranian isolates are showed in red and global H9N2 isolates in black. Different introductions 
and circulation date are reported behind of each clade. 
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Iranian H9N2 AIVs phylogeographic analysis 
In order to determine the Iranian dissemination of H9N2 AIVs, the HA gene sequence 
alignment including the Iranian viruses and the most related clades was used for in-depth 
analysis. Through Posterior distribution under the Bayesian framework, genealogical trees 
with time-scale and inferred ancestral locations of each branch were reconstructed using 
sequences sampling collection dates and locations. The time-scaled phylogeographic 
maximum clade credibility (MCC) trees of HAs implemented in BEAST and the root state 
posterior probability are illustrated in Figure 2, in which the most probable location of each 
branch is assigned by different colors and by calibrating time-scale. Numbers at branch points 
in Figure 2 are reported where state probabilities with values ≥0.55 correspond to the most 
relevant events (i.e. country-country rather than intra-country transitions). Such transition 
events are graphically shown in Figure 3 world map distribution. Phylogeographic results 
suggest that the first Iranian H9N2 AIV introduction is of Chinese origin and it can be 
considered as ancestor of the Iranian clade B.1.1 viruses. Interpreting phylogeographic and 
phylogenetic trees, clades B.1.1 enclose the oldest Middle eastern H9N2 viruses, which are 
the oldest clades evolved in Middle East. Except for one case in Saudi Arabia, the clade B.1.1 
evolved only in Iran; further, Iran may be the first country where H9N2 started to evolve. The 
ancestor of Iranian strains belonging to clade B.2.1 is likely to have been introduced from 
Pakistan. The viruses of clade B.2.1 did not circulate in any other country and, as for first 
Iranian introduction, evolved only in Iran. The last two Iranian introductions, belonging to 
clade B.2.5 and B.2.3, originated from Pakistan and, before the introduction in Iran, they had 
already evolved and circulated in that country. Iran contributed to the eastward spread of 
viruses from clade B.2.5 to the Afghanistan. The overall spatiotemporal representation of 
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phylogeographic evolution and spread of the H9N2 viruses is presented in Supplementary 
visual animation S1 (JUST ONLINE). 
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Figure 3. Phylogeography mapping and spreading of H9N2 AI viruses in Iranian and Middle-East countries. Viral transition from a 
geographic area to another one with the well supported Bayes factor > 3 and state probabilities values ≥ 0.55 are represented by lines. 
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Figure 2. Maximum clade credibility (MCC) phylogenies inferred for the HA gene 
sequences of Iranian and Middle-East H9N2 AI viruses. Branches are coloured according 
to the most probable ancestor location (in terms of geographic area) of their descendent 
nodes. Timeline at the bottom indicates the years before the most recent sampling time. 
Numbers are reported at branch points where state probabilities with values ≥ 0.55 correspond 
to geographic area transition events.  
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Evolutionary rates and selection pressure 
The selection pressures of the Iranian H9N2 AIVs were estimated by assessing the overall 
number of non-synonymous to synonymous substitutions (dN/dS) The same two sites in the 
HA gene were under a positive selection pressure by at least three computational models with 
significant statistical values (http://www.datamonkey.org), FUBAR (posterior probability 
0.99), FEL, IFEL and SLAC (p-value for all 0.01-0.0005). Nevertheless, three individual 
codons were found under positive selection. The amino acids, which were found to be prone 
to changes, were 198, 234, and 267 (H9 numbering). corresponding to positions 190, 226, and 
259 of the AIVs H3 numbering. The finding of the three identified amino acids, located in 
antigenic sites the amino acid positions 190 and 226, is extremely important since they have 
been previously shown to be responsible for potential antigenic and adaptive changes. 
substitutions E190D and Q226L at the receptor binding domain of the HA molecule (H3 
numbering) are essential for the horizontal spread of H9N2 AIV in mammals (Sorrell et al., 
2009) Furthermore, site 234 (226 in H3 numbering) falls within epitope II of H9 and plays a 
role in the receptor binding specificity of HA (Kaverin et al., 2009). The evolutionary rate of 
all Iranian viruses from 1998 to 2014 calculated by BEAST was 5.2 x 10
-3
 
substitutions/site/year (95% HPD from 4.04 x 10
-3
 to 5.07 x 10
-3
 subs/site/year) and the mean 
time of the most recent common ancestor (TMRCA) was estimated to be around 1996 (95% 
HPD from 1998 to 1993). Equivalent analysis using root-to-tip regression against sampling 
time (program Path-O-Gen) was performed and the result was 6.58 E
-3
 substitutions/site/year 
(correlation coefficient: 0.98, R squared-0.96) according to BEAST results. The correlation 
and the possible effect of poultry vaccination program (implemented in the 2000s) on 
selection pressure was investigated, by analyzing the HA protein of all Iranian isolates 
circulating from 1998 to 2000 when vaccination had not been introduced and of the strains 
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from 2000 to 2014 when the vaccination was enforced. The results showed that the strains 
circulating from 1998 to 2000 had no any amino acids under selective pressure. Conversely, 
three codons were predicted to be under positive selection in the Iranian viruses circulating 
from 2001 to 2014. The three identified codons are the same previously described above for 
all Iranian viruses. Although the number of positive selected sites may be affected by sample 
size, the codons predicted to be under positive selection, in particular among strains 
circulating under vaccination programs alone, support the hypothesis that there is a positive 
selection due to vaccination. The comparison of the evolutionary rates of the clade B.1.1 
comprising the viruses of the first introduction and the clades B.2.1 and B.2.5 reveals that it 
has not had a great success because the number of viruses for each clade is not enough and the 
Iranian clades, particularly clade B.2.5, has not an evolutionary history and consequently it is 
not possible to calculate the evolutionary rate separately for each introduction and compare 
them with each other and with different countries. 
 
Specific amino acid evolution history 
The amino acid sequence analyses of the Iranian H9N2 AIVs showed that the first 
introduction (clade B.1.1) consists of 50% (16/32) of strains with amino acid Q at position 
226 (H3 numbering) and 50% with L226 substitution. Interestingly, other introductions 
comprise mainly (>97%) strains with the amino acid L226. With the phylogenetic Bayesian 
tree along with amino acid sequence distribution, the evolution and character history of amino 
acid 226 (H3 numbering) was reconstructed by Mesquite software (Figure 4). Results show 
that the ancestors of all Iranian H9N2 viruses had an amino acid L. The ancestors of clade 
B.1.1 were probably viruses with amino acid Q, whereas for the other clade there was an 
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amino acid L. This result suggests the presence of selection pressure from viruses with the 
amino acid Q to the amino acid L. 
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Figure 4. Amino acid 226(Q/L) evolution trend of Iranian H9N2 viruses. Mesquite tree shows the presence of AA 226 (Q/L) in each Iranian 
viruses and the percentage in each introduction.
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Discussion and conclusion 
Since 1998, avian influenza H9N2 viruses rapidly evolved and continuously circulated in 
the Iranian poultry population. The overall picture revealed by our analyses confirms that 
Iranian H9N2 AIVs evolved genetically with high evolutionary rates and in spite of the 
implemented national control measures, including mass vaccination of poultry, the virus 
rapidly spread and currently it can be considered endemic in the Iranian poultry. Phylogenetic 
analysis of Iranian strains, circulating from 1998 to 2014, revealed the presence of four 
distinct introductions, which grouped exactly within the four clades. It is worth to highlight 
that a new introduction seems to start when the previous one decreases. Otherwise, when the 
virus of a dominant clade decreases the beginning of a new introduction is observed. On the 
basis of the TMRCA results, the first detection of H9N2 AIVs in Iran occurred late after their 
common ancestor, which is estimated around 1996. However, the late detection (in 1998) 
probably contributed to the circulation and evolution of the virus in the country. Interestingly, 
the Iranian H9N2 shows evolutionary rate values similar to those of the Egyptian and the 
Indonesian H5N1 viruses (Cattoli et al., 2010). 
In this study, we also noted that the HA gene sequences of the Iranian viruses, circulating 
during the vaccination program, seemingly had greater numbers of positively selected sites 
compared to the HA sequences of viruses circulating before the implementation of 
vaccination programs. Unfortunately, it was impossible to evaluate the rates of nucleotide 
substitutions among the different introductions, before and after the vaccination program. 
However, the direct association between the H9N2 vaccination and evolution is difficult to 
establish since other factors, difficult to evaluate under field conditions, might have 
contributed to the apparent differences in evolutionary dynamics. For example, poultry 
density, various ecological factors or environmental changes, may have contributed to the 
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different rates of nucleotide substitution and strength of natural selection in viruses circulating 
in poultry (Suarez, 2010; Vandegrift et al., 2010). It is reported that, when properly planned 
and implemented, vaccination is a powerful tool for the control and eradication of avian 
influenza in poultry, as demonstrated by past experiences in Italy, Vietnam and Hong Kong 
(Capua and Marangon, 2007; Ellis et al., 2006; Domenech et al., 2009), where it reduced the 
economic losses and the risk for zoonotic transmission. However, if not properly applied and 
not coupled with careful surveillance, robust vaccine strategy, use of recommended 
commercial vaccines in agreement with the dominant viruses and strict biosecurity measures, 
vaccination may contribute to the rapid evolution and antigenic change of AIVs by creating 
opportunities for the viruses to escape from vaccine protection. The molecular analysis of 
Iranian H9N2 viruses demonstrated that those harbouring the Q226 mutation apparently are 
no longer circulating, and the recent strains contain the L226 mutation. This result indicates 
that the Iranian H9N2 AI viruses may have specific molecular markers for the infection of 
mammals, and poultry vaccination may lead the viruses to human adaptation. Thus, there is a 
need for a continue monitoring and surveillance of H9N2 viruses to identify the evolution and 
the adaptation of these viruses to humans in order to prevent potential future outbreaks. In 
addition, the Bayesian phylogeographic analysis framework was applied to determine the 
source, migration patterns, and the corresponding demography history of the H9N2 AIVs 
circulating in Iran. The results suggest that the first introduction originated from Chinese 
viruses evolved in Iran by forming the clade B.1.1, and the subsequent introductions occurred 
in Iran had the original source from Pakistan. Contrary to that observed in the first two 
introductions that circulated and evolved only in Iran, the last two introductions comprising 
the clades B.2.3 and B.2.5 had already circulated and evolved in the neighbouring countries 
and subsequently introduced in Iran from Pakistan. The H9N2 virus introduction/migration 
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seems to have occurred basically from the eastward area, particularly between Iran and 
Pakistan. It is also interesting to note that the last two Iranian introductions occurred in recent 
years from Pakistan, the viruses were introduced in Iran and from Iran were exported to 
Afghanistan. In conclusion, reinforcing surveillance and control measures would be useful in 
order to prevent future introductions and circulation of outside H9N2 AIVs from migratory 
birds, poultry trade, and transportation. 
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Chapter 5  
 
CONCLUSIONS 
Emerging infectious diseases represent a significant public health threat worldwide. 
Influenza A virus is a zoonotic agent with a significant impact either on public health and the 
poultry industry. Avian influenza (AI) H9N2 viruses are currently circulating in the Middle 
and Far Eastern, as well as in European poultry, and the infection is endemic in several 
countries. H9N2 influenza viruses have human virus-like receptor specificity and potentially 
they could cross the species barrier and switch to human host. Therefore, surveillance and 
characterization of new isolates are needed by the scientific community and public health 
systems. One of the aims of this thesis was the serological investigation of H9N2 avian 
influenza virus exposure among poultry workers in one of the Middle Eastern endemic 
countries, as Iran. Through the application and comparison of two different serological tests 
human serum samples from Fars province of Iran were analysed to reveal the potential 
exposure of poultry workers to H9N2 AI viruses. The results of this research confirmed an 
association between professional exposure to poultry species and the presence of antibodies to 
the Iran 2008 H9N2 (human like) virus. Furthermore, these results were obtained from a 
collaboration among different international research groups and highlighted the potential 
transmission of avian H9N2 AIVs to humans and that poultry workers of Fars province (Iran) 
are at risk of infection. We discussed about our findings with the Iranian research group 
involved in this project and provided our feedback about future surveillance and research 
activities to minimize the risk of exposure in poultry operators and prevent the public heath 
from a future influenza pandemic. 
  
136 
Phylogenetic analyses and evolution dynamics of global H9 viruses along with the 
proposal of a unified nomenclature system has been another topic of this research project. The 
phylogenetic grouping structure, the evolutionary dynamics and the origin, herein described, 
provided a better understanding of the complexity of the H9 viruses evolution. In addition, 
phylogenetic analysis along with spatial dispersal patterns obtained by phylogeographic 
investigations contributed to the creation of a genetic classification of the H9 viruses. This 
system can be proposed to the scientific community as standard nomenclature to unify the 
results. In fact, recently the FAO has shown interest to the proposal of a unified standard 
nomenclature for the H9 subtype (as the H5 ones) and requested the collaboration of different 
research groups. IZSVe has collaborated to this project and provided these results that should 
be evaluated, approved and maybe used in the standard nomenclature of the H9 AI viruses 
that hopefully will be proposed. 
The phylogenetic and the evolutionary history of the H9N2 viruses in Iran from 1998 to 
2014 were also targeted in this research project by analyzing an endemic country as Iran 
where a national vaccination program is implemented. The results demonstrated the presence 
and the origin of different genetic group introductions. In addition, a selection pressure on 
circulating viruses operated by the vaccination was revealed, as well as the mutation history 
of a very important amino acid Q/L 226 (H3 numbering) was traced demonstrating that 
Iranian H9N2 viruses shifted from avian like to human like. In fact, in the first project the 
seropositivity of the Iranian operators was against the human like viruses which confirms the 
adaption of this viruses to humans.  
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